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INTRODUCTION 
Since the recognition of chronic pneumonia of swine as a disease 
entity distinct from Swine Influenza, its etiology has been the subject of 
much conflict and confusion. The disease has been variously called 
"Infectious Pneumonia of Pigs", "Swine Enzootic Pneumonia", and "Virus 
Pneumonia of Pi gs". Recent research by independent groups of investigators 
has established that the most common cause of chronic pneumonia in swine 
is a mycoplasmal infection. The causative mycoplasma has been charac-
terized and named My cop las ma hyopneumoni ae. In recognition of the 
importance of etiology in the description of the disease, the name 
"Mycoplasmal Pneumonia of Swine" will be used in the present study. 
Mycoplasmal pneumonia of swine is characterized clinically by non-
productive cough, high herd morbidity,· low mortality, loss of vigor, 
retarded. growth, and decreased feed efficiency. Gross pneumonic lesions 
occur most frequently in the apical, cardiac, and intermediate lobes of the 
lungs, and are marked by grey to reddish colored areas clearly demarcated 
from normal lung tissues. The lesion is characterized by peribronchiolar 
and perivascular lymphoid hyperplasia, alveolar interstitial thickening, 
septal cell proliferation and neutrophil infiltration. 
Mycoplasmal pneumonia of swine has been reported in almost all major 
swine producing countries of the world. The disease has been described as 
the world's most prevalent and most important respiratory disease of swine. 
Economic 1 oss which the disease causes to swine industry has been estimated 
in hundreds of millions of dollars annually. 
Efforts at control of the disease have been centered on measures ·which 
I 
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break the cycle of infection. However, such measures as depopulation of 
infected herd and repopulation with surgically derived or specific 
pathogen-free (SPF) swine have not proved very successful. Chemotherapy 
and chemoprophylaxis have proved ineffective in the elimination of the 
causative IJ\YCOplasma from the lungs and in prevention of spread of the 
organism to in-contact pi gs. There is, therefore, a need for research on 
the development of autogenous vaccines and on the application of immuniza-
tion as an alternative or complementary control measure. 
The present study was designed to evaluate the ability of 
M. hyopneumoniae vaccines to provide protective immunity in susceptible 
pi gs, and to cure swine a 1 ready infected with the organism. 
;, . 
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REVIEW OF THE LITERATURE . 
Literature reviews on enzootic or mycoplasmal pneumonia of swine 
have been presented by Betts (1953), L'Ecuyer (1962), Mar~ and Switzer 
(1965), Mar~ (1969), Huh.n (1970), Lam (1970), and Slavik (1971). The 
present literature review is not intended to cover all aspects of this 
disease but will concentrate on three relevant areas: (1) Major develop-
ments in the identification of the etiologic agent and the definition and 
nomenclature of the disease entity; (2) Serologic Tests for Mycoplasma 
hyopneumoniae; and (3) Immunization against Mycoplasma Infections in 
Humans and in Animal Species. 
Mycoplasmal Pneumonia of Swine 
Shope (1931) first described Swine Influenza in swine herds in 
eastern Iowa. The respiratory disease he studied was transmissible with a 
short incubation period. It was characterized histologically by 
atelectasis, peribronchial round cell infiltration and desquamation of 
bronchiolar epithelium. He demonstrated that swine influenza was caused 
by the synergistic action of the swine influenza virus and Hemophilus 
influenzae suis. In addition to swine influenza, he noted a second 
respiratory disease characterized by low morbidity, absence of prostration, 
and greater chronicity. He cautioned that swine influenza was not the 
only pneumonia present in swine. 
In the decade following Shape's classic work, many investigators 
described any pneumonic condition in pigs as some form of swine influenza. 
Kobe (1932) applied the name "Ferkelgrippe" (piglet influenza) to a 
chroriic respiratory disease of young pigs in Germany. He believed the 
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causative agent was a low-virulence variant of the swine influenza virus. 
Glasser (1939) observed that the disease reported by Kobe occurred in both 
young and old pi gs; he therefore used the more general term 11 Schweingrippe 11 
(swine influenza) to describe it. 
Pullar (1948) reported the occurrence of a chronic pneumonia which he 
considered the most important disease of pigs in Australia. He differen-
tiated it from swine influenza, noting that its etiologic agent was 
unknown. This respiratory condition appeared to be transmissible so he 
referred to it simply as "Infectious Pneumonia". 
While attempting to isolate swine influenza virus in England, 
Gulrajani and Beveridge (1951) recognized a transmissible pneumonia which 
differed clinically and serologically from swine influenza. They were 
unable to isolate the virus of swine influenza from the naturally and 
experimentally transmitted cases. They isolated another filtrable agent 
which reproduced the chronic low-grade pneumonia following intranasal 
inoculation of pigs. The gross lesions of the pneumonia were apparent 12 
to 16 days post-inoculation. Hemagglutination-inhibition tests for 
antibody agai ns t swine influenza virus were repeatedly negative. Gulrajani 
and Beveridge ca 11 ed the disease 11 Infectious Pneumonia of Pi gs 11 because 
they considered the disease similar to that described by Pullar (1948) and 
because the name was nonconmittal with regard to etiology . 
In the following year, Betts (1952) reported clinical and 
epidemiological studies which supported the finding that infectious 
pneumonia was distinct from swine influenza. He described the macroscopic 
lesion as plum or greyish colored and clearly demarcated from the normal 
lung tissues. Pneumonic lesions were frequently confined to the cardiac 
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and apical lobes, with the diaphragmatic lobes less frequently affected. 
His attempts to detect mycoplasma-like organisms in smears of lung tissues 
and by culture were unsuccessful; the procedure and medium he employed 
were not indicated. The infective agent passed through bacteria-retaining 
filters and was re-isolated by intratracheal injection into susceptible· 
pigs. Betts observed that the etiologic agent was susceptible to the 
antibiotic, AureoTI\Yci n. This was probably the first i ndi ca ti on that the 
causative agent was nonvi ral. However, Betts co.nsidered the agerit to be a 
large virus and applied the name "Virus Pneumonia of Pigs" (VPP) to the 
disease. During the next 14 years, while the concept of a viral etiology 
prevailed, this name became widely accepted. 
Goodwin and Whittlestone (1963) introduced the designation "Enzootic 
Pneumonia" in their description of the chronic disease. They applied this 
name because the transmissibie pneumonia was very common or· "enzootic" in 
swine populations. They also preferred that name to "Virus Pneumonia of 
Pigs" because they believed the etiology had not been established 
satisfactorily. 
Mar~ (1965) and Mar~ and Switzer (1966) have reviewed the·attempts 
made by many investigators to propagate the agent in embryonated chicken 
eggs and in cell cultures. L'Ecuyer (1962) and L'Ecuyer.and Switzer 
(1963) successfully propagated the etiologic .agent in primary cultures of 
swine kidney and in human cervical carcinoma (Hela) cell cultures. 
Respiratory disease-free pigs inoculated intranasally and intratracheally 
with the cell culture fluids developed typical gross lesions. These 
lesions were characterized by perivascular and peribronchiolar lymphoid 
hyperplasia and alveolar interstitial thickening. The fourth serial. 
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passage in the cell cultures was the highest passage that reproduced the 
' ' . 
pneumonia. No ·cytopathic effects were detected in the inoculated cell 
cultures. L'Ecuyer suggested. that the cells or the culture fluid allowed 
the agent to propagate in an inapparent manner. 
Betts and Whittlestone (lg63) and Goodwin and Whittlestone (1963) 
detected cytopathic effects in plasma-clot cultures prepared from the 
pneumoni c 1 ung of a pig experimentally infected with a bacteria-free 
Cambridge "J" strain of the infective agent. .They a 1 so produced similar 
effects in pi g-1 ung monol ayer cultures inoculated with tissue culture 
fluids from the plasma-clot cultures. Early passage material inoculated 
into a pig produced typical lesions. They were able to detect pleomorphic 
organisms in the cell cultures and in the pneumonic lesions. They 
mentioned the likelihood that the organism might fall in the 
pleuropneumonia-'like organism (PPLO) group. 
Goodwin and Whittlestone (1964) propagated the "J" strain in boiled 
pig lung cell cultures and in cell-free medium enriched with infusion broth· 
and yeast extract. They consistently detected the pleomorphic organisms 
in the cultures and in touch preparations of· lesions experimentally 
induced with high dilutions of the culture fluids. Their work showed that 
the eti ol ogi c agent could not be a virus, and a ltho.ugh they suggested that 
the J agent probably was a PPLO, they did not substantiate or prove it. 
Mare (1965) and Mare and Switzer (1965) propagated strain 11 of the 
swine pneumonia agent they worked with in cell-free medium composed of 
Dulbecco Phosphate Buffer (DPB) and Beef Heart Infusion (BHI) with yeast 
extract enrichment. Seventh, eighth, and twenty-fifth serial passages 
of the fluid culture inoculated intranasally into respiratory disease-free 
, 
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pigs produced the characteristic gross and histologic lesions of enzootic 
pneumonia. The agent was successfully reisolated in cell-free medium from 
the experimentally produced lesions. Microscopic examination of Gi emsa-
sta i ned touch preparations of the pneumonic lungs revealed coccoid to 
cocco-baci 11 ary organisms. After further characterization the organism was 
found to be between 110 and 220nm in diameter, ether- and chlortetracycline-
sensitive, and penicillin-resistant. It formed very mfoute colonies on 
solid medium. On the basis of these findings, Mare and Switzer named the 
organism Mycoplasma hyopneumoniae (Mycoplasma of swine pneumonia). ~his 
constituted the first published evidence establishing that the etiologic 
agent of the disease was in fact a Mycoplasma. 
Some months later, Goodwin, Pomeroy, and Whittlestone (1965) reported 
the propagation of their "J" strain agent on solid medium and observation 
of pleomorphic mycoplasma-type elements in stained touch preparations from 
the colonies. The organism was serially passaged on solid.medium. Such 
cultures were. used to induce typical lesions in experimental pigs. The 
morphology, growth requirements, and antibiotic sensitivity of the organism 
were generally similar to those described by Mare and Switzer (1965). 
They assured themselves that th.e agent was a Mycoplasma species and 
proposed the name Mycoplasma suipneumoniae (Mycoplasma of swine pneumonia) 
for it. 
Estola and Schulman (1966) reported the isolation of mycoplasma 
strains from cases of swine enzootic pneumonia in Finland. They used 
.embryonated hen's eggs, PPLO agar, and tissue cultures for the isolation 
of these organisms. 
Goodwin, Pomeroy, and Whittlestone (1967) reported additional work on 
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their "J" agent which confirmed that it was a mycoplasma species. By the 
growth-inhibition and metabolic-inhibition tests they found that 
Ji. suipneumoniae and Ji. hyopneumoniae were antigenically indistinguishable. 
Both were, however, shown to be serologically distinct from known 
mycoplasmas isolated from the pig and other animal species. 
L'Ecuyer (1969) recovered three strains of a mycoplasma species from 
the pneumonic lung of pigs in Canada. He was able to reproduce the disease 
by i ntratrachea 1 inoculation of respiratory disease-free pi gs with the 
mycoplasma prop.agated in an enriched cell-free medium or in pig testicle 
cell cultures. The m.ycoplasma was reisolated from the pneumonic lung of 
the experimentally infected pig. He did not attempt to assign any 
specific name to his mycoplasma isolate. 
Hodges, Betts, and Jennings (1969) observed that earlier investigators 
in England and the United States had reproduced enzootic pneumonia in 
first and subsequent generation specific pathogen-free (SPF) or respiratory 
disease-free pi gs but not in "germ-free" pi gs. They pointed out the 
possibility that apparently nonpathogenic micro-organisms normally present 
in the respiratory tract of conventionally-reared SPF swine may have been 
involved in the production of.the pneumonic lesions. They used as inoculum 
a mycoplasma which they isolated from the lungs of a pig experimentally 
infected with the "J" strain of enzootic pneumonia. A pure culture of the 
organism produced by terminal dilutions was found to be serologically 
indistinguishable from Ji. hyopneumoniae supplied by Switzer. They 
produced pneumonia in both gnotobiotic and SPF pigs by a single inoculation 
with the pure culture. From the SPF pigs they collected nasal washings 
which contained severa 1 bacteria 1 species but no mycopl asma; the nasa 1 
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washings failed to elicit the pneumonia. Their work confirmed that 
M. hyopneumoniae is a primary etiology of swine enzootic pneumonia . 
. In Denmark, Friis (1969) reported the isolation from the pneumonic 
lung of pigs of an agent which he found to be culturally and serol.ogically 
identical to .!1· hyopneumoniae. 
In the same year Takatori (1969) demonstrated a serologic relationship 
between .!1· hyopneumoniae and the "M" strain of SEP in Japan which suggested 
that the "M" strain is .!1· hyopneumoniae. 
Mycoplasma hyopneumoniae is the only mycoplasma which has been 
demonstrated, beyond any reasonable doubt, to cause enzootic pneumonia of 
swine. There are, however, conflicting reports regarding the role of a 
few other species of mycoplasma in this disease. One of these, Mycoplasma 
hyorhinis, a polyserositis--producing mycoplasma, was first isolated by· 
Switzer ( 1955) from both normal and pneumoni c lungs of P.i gs. Si nee then, 
several investigators have concluded that .!1· hyorhi ni s was a secondary 
invader in cases of mycop l asma l pneumonia ( L' Ecuyer et tl· , l 961 ; L' Ecuyer 
and Switzer, 1963; sw.itzer, 1967; Goodwin ~tl·• 1967, 1968; Goodwin and 
Hurrell, 1970). These investigators noted that .!1· hyorhinis readily over-
grows .!1· hyopneumoniae and that this fact often creates difficulties in the 
isolation of the etiologic agent of swine mycoplasmal pneumonia. In order 
to overcome this problem of mixed cultures in the primary. isolation, 
Goodwin et tl· (1968) have suggested the use of the pig as a selective 
medium. Goodwin et tl· (1970) and Friis (197la) have developed an isola-
tion technique that involves serial dilution of the pneumonic lung and a 
prolonged incubation period. 
Some recent reports have incriminated M. hyorhinis in the primary 
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etiology of swine mycoplasmal pneumonia. In Czechoslovakia, Gois et tl· 
(1968) and Geis et tl· (1970) believed they produced enzootic pneumonia 
with "cloned" cultures of TR32 strain of M. hyorhinis inoculated into both 
conventional and. gnotobiotic pigs. They classified the isolate as 
!'.!· hyorhinis on the basis of colonial growth and metabolic-inhibition 
tests. There were no uninoculated control pigs in the experiment. 
Po 1 and et tl· ( 1971) in Engl and reported an extension of the work of 
Goi s and his colleagues. Three of 9 gnotobi oti c piglets exposed to an 
aerosol of the TR32 strain of !'.!· hyorhinis developed pneumonic lesions. 
However, 2 out of the 3 also developed pleuritis; one pig had a broncho-
pneumonia which histologically resembled typical enzootic pneumonia. 
Mycoplasma hyorhinis was reisolated from the lungs of the inoculated pigs, 
irrespective of the presence or absence of lesions, ·but was isolated from 
the serosa and joints only when lesions were present. All the inoculated 
pigs developed some type of serositis. This indicates that the primary 
lesion produced by M. hyorhinis infection is polyserositis. 
Friis (197lb) inoculated 12 hysteroctomy-produced, colostrum-
deprived pigs with high dilutions of!'.!· hyorhinis isolated from various 
cases of swine pneumonia in Denmark. Two of the inoculated pi gs deve 1 oped 
pneumonic lesions. Mycoplasma, identified as M. hyorhinis by the. growth-
inhibition test, were recovered from the lesions as well as from normal 
areas of the lu.ngs. The same mycoplasma were recovered from the brain and 
nasal cavity of inoculated pigs. The pneumonic lung lesions were negative 
for M. hyopneumoniae when examined by means of the fluorescent antibody 
test. 
Dzu et tl·. (1971) reported the production of lesions typical of 
' 11 
enzootic pneumonia and atrophic rhinitis in specific pathogen-free (SPF) 
swine inoculated with both Mycoplasma laidlawii and Pasteurella multocida. 
Pigs inoculated with _ti. laidlawii strain J252 first and then Pasteurella 
strain 81297 developed more extensive lesions than those that received 
only mycoplasma, or pasteurella first and then mycoplasma. Most of the 
inoculated pigs also developed serositis. Antibodies against the 
mycoplasma strain were detected by the slide-agglutination, growth-
inhibition, metabolic-inhibition, and the indirect hemagg.lutination tests. 
Reisolation of the inoculated strain of mycoplasma and pasteurella was 
reported successful in all test animals. 
These independent groups of investigators have provided evidence that 
the etiologic agent of a widespread, chronic pneumonia of swine is 
mycop.l as ma l ·in nature. Therefore the use of the name "Virus Pneumonia of 
Pigs" (VPP) for this condition is inappropriate and misleading, and should 
. ' 
be abandoned. Marl'! (1969) has stated that the term "Swine Enzootic 
Pneumonia" (SEP) is based solely on epidemiological characteristics of a. 
field disease and evades the issue which has been the major concern of 
many investigators; that is, the etiology of disease. He favored the 
designation "Mycoplasmal Pneumonia of Swine" because it is more accurate 
and specific and makes allowance for additional species of Mycoplasma which 
may induce similar disease in pigs. Huhn (1970) stated that while.the 
term "Mycoplasmal Pneumonia of Swine" is etiologically suggestive, it 
does not differentiate between the primary and secondary nature of the 
incriminated agents. He preferred the use of "Enzootic Pneumonia of Pigs" 
which he considered to be an etiologically neutral term. However, several 
workers, particularly in the United States, have used the designation 
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"Mycopl asma 1 Pneumonia of Swine" in their pub 1 i cations (Mar~, 1969; 
Slavik, 1971; Lam and Switzer, 1972; Switzer, 1972). In 1971, the 
Committee on Nomenclature of the Colloquium of the American Veterinary 
Medical Association recommended the. adoption of the term "Porcine 
My cop 1 as ma 1 Pneumonia". This indicates a recognition by the members of 
this committee, of the significance of the etiology in the definitiOn and 
nomenclature of the disease entity. 
Serologic Tests for Mycoplasma hyopneumoniae 
Successful propagation and i denti fi ca ti on of the etiologic ,agent of 
mycoplasmal pneumonia of swine has made possible the production of specific 
anti gen and the deve 1 opment and app 1 i ca ti on of different serodi agnostic 
tests for the disease. 
Metabolic-inhibition tests 
Goodwin et tl· (1967) indicated that immune sera produced inhibition 
of acid production by the swine pneumonia agent. They compared 
.!1· hyopneumoniae and M. suipneumoniae by the metabolic-inhibition test and 
found the two isolates to be serologically indistinquishable. Hodges et tl· 
(1969) also used the metabolic-inhibition test to show there is a close 
antigenic relationship between .!1· suipneumoniae and~- hyopneumoniae. · 
Takatori et tl· (1968) were unable to detect any metabolic-inhibition 
activity in the serums of pi gs experimentally infected with 
~· hyopneumoni ae. Goodwin et tl· ( 1969a) a 1 so reported that they could 
not demonstrate specific metabolic"inhibition antibody against 
.!1· sui pneumoni ae in serums from infected pi gs. Instead, they detected 
nonspecific inhibitory substances in some normal and infected pigs. 
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Takatori (1970) has reported that while metabolic-inhibition is an 
encouragi.ng test for detection of mycoplasmal antibodies in other animals, 
it seems of little value for detection of Mycoplasma hyopneumoniae antibody 
in infected pigs. 
Agglutination tests 
Moore et 2..!_. (1965) described a direct plate agglutination technique 
for )1. hyopneumoniae and four other mycoplasma species in swine. Antigens 
preserved in 0.24% phenol and antiserums serially diluted two-fold were 
used in the test. The test was performed in wells of a glass plate and 
consisted of 0. 05ml of the anti gen mixed with 0. lml of the serum dilution. 
After overnight incubation at 4°c the test was read. These workers noted 
that inactivation of the antiserum prevented the agglutination reaction. 
They indicated that complement was probably necessary in the reaction. 
Roberts and Little (1970a) employed a stained antigen plate .agglutina-
tion test to determine the serologic response of pigs to two strains of 
)1. hyopneumonfae. A mixture of one drop of the serum from an infected pig 
and an equal volume of the stained antigen was made on an enamel plate at 
room temperature. The plate was rotated and the test read after 3 minutes. 
No slide agglutination reaction was demonstrated. 
Fujikura et 2..!_. (1970) reported a workable tube-.agglutination test 
which was interpreted on the basis of clearing and settling of the antigen . 
. Using this test, they demonstrated antibody against )1. hyopneumoniae in 
infected pi gs. The test serum was inactivated at 56°C for 30 minutes. 
They performed the test in glass tubes and utilized a total reaction 
volume of O.Sml consisting of equal volumes of the antigen and two-fold 
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dilution of the inactivated antiserum. The mixture was first incubated in 
a water bath at 37°C for 2 hours and then in a cold room at 4 to 5°C for 
another 18 hours. There was a relatively good correlation between the 
presence of mycop 1 as ma 1 pneumonia 1 es ions and detectab.l e aggl uti nati ng 
antibody titers. The test appeared to be specific since no cross-reaction 
was demonstrated between !1· hyopneumoni ae and !1· hyorhi ni s anti gens with 
the heterologous immune serums. In pigs less than 3 months of age, the 
agglutinating antibody was demonstrated at a higher frequency than was the 
complement-fixing antibody. 
Indirect-hemagglutination tests 
Moore et al. (1965) described·an indirect-hemagglutination (IHA) -- .. 
method which they claimed could allow the. grouping of J1. hyopneumoniae and 
other swine mycoplasmas into species on a more precise basis. The 
respective antigens were standardized to a Macfarland Nephalometer reading 
of 10. An unspecified amount of the saline-suspended organisms was boiled 
in a water bath for 10 minutes, then cooled to room temperature and an 
equal volume of 5% washed sheep red cells was added. The mixture was 
incubated at 37°c for 2 hours. The cells were then washed three times in 
0.85% saline and resuspended to a 5% concentration. ·The test was performed 
by mixing 0.05ml of the sensitized cells and O. lml of two-fold serial 
dilution of the test serum. After a 20-minute incubation period, the test 
was read by bbservi ng aggl uti nation of the red b 1 ood cells. No eva 1 uation 
of the test was. given by the authors. 
Goodwin et!}_. (1969a,b} used a tube indirect-hemagglutination test 
to demonstrate. immune antibody against J1. hyopneumoniae. They utilized 
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sheep red blood cells treated with tannic acid and sensitized with the 
mycoplasma ant.igen. Tubes containi,ng the test serum dilutions and the 
sensitized red blood cells were incubated at 37°C for 2 hours. After 
initial reading, the tubes were incubated overn.i ght at room temperature 
before the final readi,ng was made. The highest dilution of serum giving a 
clearly positive agglutination was taken as the end-point. These investi-
gators reported that the i ndi rect-hema.ggl uti nation anti body appeared later 
and lasted lo.nger than the complement-fixing antibody. Recovered pigs had 
antibody titers. greater than l :40,000, as measured by the IHA test. 
Goodwin and Hodgson (1970) reported a passive hemagglutination test 
(PHA) for the detection of .!1· hyopneumoniae. The test was a modification 
of the IHA test described by Goodwin et _tl. (1969). These workers found 
that tannic acid in the final concentration of l :100,000 yielded a superior 
final suspension of cells and that sensitization of the tanned red blood 
cells for 30 minutes at 37°c gave a better ant.igen. They used the PHA 
test to diagnose 14 cases of mycoplasmal pneumonia which had earlier 
presented diagnostic difficulties with the metabolic-inhibition test. 
Lam and Switzer (1971) developed an indirect-hema.gglutination test 
for the detection of antibodies to .!1· hyopneumoniae in experimentally and 
naturally infected pi gs. The ant.i gen was prepared by adding 2% so di um 
lauryl sulfate (SLS) to the concentrated mycoplasma suspension to obtain a 
final concentration of 0.2%. The suspension was dialyzed first against 
SM ammonium sulfate overnight and then .against phosphate buffered saline 
for 72 hours. Thimerosal was added to produce a final concentration of 
l :10,000. In order to avoid the naturally occurri.ng hemolysin in test 
swine serum to sheep red blood ce 11 s, these i nves t.i gators used swine red 
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blood cells as antigen-carrier in place of the conventional sheep 
erythrocytes. A mixture of the antigen, buffer, and 10% tannic acid-
treated erythrocytes was incubated in a water bath at 37°c for 20 minutes. 
The antigen-sensitized cells were then suspended to obtain a f1nal 
concentration of 1%. The final test was conducted in trays, each weil 
containing O.OSml of the serum dilution and 0.025ml of the ant.igen-coated 
cells. The mixture was incubated at 37°C for 1 hour before reading the 
test. A titer of 1 :12 or higher was considered positive for. 
!i· hyopneumoniae. The test detected antibodies in 92% of experimentally 
inoculated pigs that had pneumonic lesions and 78% of naturally infected 
pigs. There was a good correlation between pneumonic lesions and antibody 
titers. No serologic cross-reaction was demonstrated when the 
M. hyopneumoniae antigen was tested against antiserums to M. hyorhinis or 
M. granularum. 
In further experiments, Lam and Switzer ( 1972) demonstrated that pi gs 
experimentally exposed to !i· hyopneumoniae developed antibody titers 
detectable by. the IHA test 2 to 3 weeks after exposure. They found that 
these titers reached a maximum on the.8th to 11th week and remained at the 
maximal level until the 18th week. The antibody was still detectable 47 
weeks post-inoculation. 
Switzer (1972) has pointed out that while the IHA test detects 
extremely high titers of antibodies that appear early in mycoplasmal 
pneumonia of swine, the test requires considerable standardization of 
reagents and· conditions and is rather difficult to depend on for consistent 
serologi c invest.i gations. 
17 
Immunofluorescence 
L'Ecuyer and Boulanger (1970) developed a useful direct immuno-
flourescent technique for the demonstration of !1· hyopneumoniae in smears 
of broth cul tu res and in pneumoni c 1 es ions. The pneumoni c 1 ung sections 
' 
were fixed with cold acetone and the specific mycoplasmal immune serum 
conjugated with fluorescein isothiocyanate was applied for staining. When. 
viewed in the fluorescent microscope the mycoplasma antigen was detected on 
the surface of the bronchial and bronchiolar epithelium and in the 
contained exudate. No fluorescence was demonstrated in known positive 
preparations stained with nonimmune pig globulin conjugates or in normal 
lungs stained with immune globulin conjugates. In experimentally infected 
pigs fluorescence was not detected until _25 days post-infection. The 
immune swine serum conj.ugates were found to be species specific; they 
reacted only with their homologous mycop 1 asma speci es--!1· hyopneumorii ae or 
_11. hyorhinis. The authors noted that by specifically allowing the 
visualization of the etiologic agent, immunofluorescent staining could 
confirm at necropsy the diagnosis established by other serologic methods. 
The technique was, therefore, considered a practical alternative to 
isolation for identifying _11. hyopneumoniae. However, the fluorescent 
antibody method appeared to be sensitive for the detection of the etiologic 
agent only in established cases of mycoplasmal pneumonia and not reliable 
duri,ng the early stages of the disease. They attributed this absence of 
fluorescence early in the disease to the difficulty in obtaining the 
appropriate sections of the 1 ungs when the areas of conso 1 i dation were very 
limited. It could also be due to an insufficient amount of the organism 
(ant.igen) being present to permit visualization. 
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Meyling (1971) reported the demonstration of!'.!· hyopneumoniae and 
M. hyorhinis in pneumcinic swine lungs by the fluorescent antibody tech-
nique. Cryos.tat sections were prepared ·from pneumonic lungs of pigs 
collected at a slaughter-house, and from the lungs of dead piglets. 
Sections were also prepared from pneumonic lungs of SPF pigs experimentally 
infected with M. hyopneumoni ae and !'.!· hyorhi ni s. The 1 ung sections were 
stained with the homologous immune serum conjugates. Mycoplasma 
hyopneumoniae was isolated by culture in 38 of the 50 slaughter-house 
cases, and in 35 of these the mycoplasma was demonstrated by the immuno-
. fluorescent method. ·In 18 cases the positive staining results. for 
· M. hyopneumoniae were not confirmed by isolation of the organism; however, 
in 15 of these!'.!· hyorhinis was demonstrated. Meyling demonstrated with 
the FA test that!'.!· hyorhinis had the same localization or distribution in 
the pneumonic lu.ng as that typical of!'.!· hyopneumoniae, and that 
!'.!· hyorhinis was in most cases found in tissue sections which were negative 
for!'.!· suipneumoniae. These findings suggested that!'.!· hyorhinis may under 
certain conditions act as a primary etiologic agent. He stated that the 
sensitivity of the direct immunofluorescent staining depends both on the 
number of organisms present in the sections and on the accessibility of 
these organisms to the labeled antibody. 
Complement-fixation test 
Until recently, the complement-fixation (CF) test was not considered 
satisfactory for the detection of antibodies in swine serums. This was 
partly because of the "procomplementary" properties of swine serums which 
significantly enhanced the hemolytic activity of the guinea7pig complement 
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as well as the occurrence of heat labile sheep red blood cell hemolysins 
in swine serums (Bankowski et 2.}_., 1953). 
Roberts (1968) first detnonstrated the presence of immune antibodies 
against!:!· hyopneumoniae in ~nheated swine serum by using the djrect tube 
complement-fixation test. Four units of a heat treated antigen were used. 
·An antigen unit was the highest dilution of the antigen which gave complete 
fixation with the highest dilution of serum in two dimensional titrations. 
The antigen, the serum dilutions, and guinea-pig complement were allowed to 
react for 3 hours at 20°c. The hemolytic system, .consisting of 3% 
suspension of sheep red b 1 ood cells sensitized with hemo lys in was then 
added. The mixture was incubated for an additional 30 minutes at 37°c and 
allowed to cool to room temperature before the test was read. There was a 
direct correlation between the level of complement-fixing antibodies and 
the degree of lung lesions. However, possible cross-reactions of the test 
serums with other swine inycoplasma species were not determined. A CF 
reaction of 1:40 serum dilution was regarded as positive because a 
"hemolytic prozone" or procomplementary effect was evident in the unheated 
serums at dilutions of 1:10 and 1:20. 
Boulanger and L'Ecuyer (1968) investigated both the direct and a 
modified-direct complement-fixation tests to determine their usefulness in 
detecting immune antibodies in pigs experimentally infected with strains 
of!:!· hyopneumoniae. In the direct CF test normal and immune test serums 
were heat-inactivated at 6o0 c for 30 minutes. At least two units of the 
titered antigen were added to two-fold serum dilutions in the presence of 
four and a half, 50% hemolytic units of guinea-pig complement. After an 
initial incubation of 18 hours at 9°C, 0.2ml of a .2.5% suspension of 
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sensitized sheep red blood cells was added, and then incubated another 30 
minutes at 37°c. The same technique was used in the modified direct CF 
test, with the exception that the complement was supplemented with 1% 
pre-tested fresh normal, unheated ·calf serum. These workers found that 
only the modified direct test was suitable for the detection of mycoplasmal 
antibodies in the heat-inactivated serums of infected pigs. The procomple-
mentary activity and poor complement bindi.ng of swine serum were masked by 
the increased sensitivity of the modified test. There was a close 
correlation between the development of pneumonic lesions in experimentally 
infected pi gs and the appearance of detectab.l e anti body titers. The 
specificity of the test was indicated by the absence of cross-reactions 
between the anti-M. hyopneumoniae serum and 11· hyorhinis or 11· granularum 
antigen; antibodies were demonstrated only with the homologous antigen. 
Takatori et ~· (1968) used another modified direct complement-
fixation test to demonstrate immune antibodies in the serums of pigs 
experimentally or naturally infected with 11· hyopneumoniae. The test was 
modified by the supplementation of the guinea-pig complement with 1% normal 
calf serum; two units of the modified complement in O.lml volume was used 
in the test. The CF antigen, consisting of a suspension.of washed 
M. hyopneumoniae organism, was found to be highly anti-complementary; 
attempts were made to eliminate or reduce this effect by ether extraction, 
heating at 56°C, boiling, or tryps i ni zati on. Complement-fixing anti body 
was first detected in experimentally infected pi gs 2 to 3 weeks after 
inoculation and tended to increase for at least 9 weeks post-inoculation. 
No cross-reactions were demonstrated between 11· hyopneumoniae, 11· hyorhinis, 
or Ji. granul arum and the heterol.ogous anti serum. Procompl ementary activity 
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was observed only in serum dilutions below 1:8; the procomplementary 
property was unpredictably neutralized by the anti.-compl ementary effect 
of the ant.i gen. 
Hodges and Betts ( 1969) demonstrated heat-1 abil e antibodies against 
the "J" strain of!':!.· hyopneumoniae by usi.ng a microtiter complement-
fixation test. They were able to detect antibodies less than 2 weeks 
after infection and the antibodies persisted for at least 15 weeks. The 
procomplementary effect of pig serum prevented the detection of antibodies· 
in titers below 1:20. Heat-inactivation of the test serums at 56°C 
resulted in very s.ignificant decreases in titer. The authors claimed a 
relatively h.igh d.egree of specificity for the test. 
Go!JdWin et~· (1969) used the CF test to study the immunity in 
experimentally induced fl\YCOplasmal pneumonia of swine. They reported that 
there was little correlation between the CF titer and the extent of 
pneumonic lesions or immune status. 
Wallis and Thompson· (1969) carried out a modified direct complement-
fixation test for the detection of antibodies .against M. hyopneumoniae in 
unheated serum samples collected from field cases of the disease. They 
claimed that heat-treatment of the immune serums at 56°c for 30 minutes 
caused the total loss .of complement-fixing capacity. They concluded that 
the complement-fixing capacity was heat-labile. Attempts to restore the 
complement-bindi.ng activity by adding normal, fresh pig serum or calf serum 
proved surprisingly unsuccessful. Procomplementary activity persisted in 
serum dilutions below 1:10, and efforts to reduce the procomplementary 
property by formaldehyde treatment were also unsuccessful. 
Boula.nger and L'Ecuyer (1970) disputed the conclusion of Wallis and 
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Thompson (1969) that their failure to obtain fixation with heat-inactivated 
swine serum meant the complement-fixing capacity was "irreversibly heat-
labile". They noted that the noncomplement-fixing antibodies in heated 
swine serums have been shown to react with !'.!· hyopneumoniae ant.igen in 
other modified CF tests (Boulanger and L'Ecuyer, 1968; Takatori et~ .. 
1968). This fact indicated that the antibodies themselves are not 
dena.tured by heating at 56°c for 30 minutes; however, certain essential 
supplementing substances are destroyed .. They discouraged the use of normal 
pig serum as a supplementi.ng factor because of its procomplementary and 
hemolytic properties. They preferred fresh normal serum from calves 
between the ages. of 3 and 12 months. Serums from calves below or above 
this age range, they said, often caused nonspecific complement-fixation in 
the presence of M. hyopneumoniae antigen. 
Roberts and Little (1970a) described a modified CF test for 
M. hyopneumoniae that utilized unheated swine serum. Heat-inactivation 
substantially decreased the CF titers, and the.addition of normal serum 
from 1-day old P.igs failed to fully restore the titers. Attempts to remove 
the procomplementary activity with formalin resulted in partial and often 
total elimination of the CF titer of both heated and unheated serum 
samples. These authors also reported that ·M. hyorhinis occasionally 
induced pneumoni c lesions; when these occurred, CF cross-reaction between 
the anti-M. hyorhinis serums and th.e !:1_. hyopneumoniae antigen was detected. 
They reasoned that the cross-reactions and the nonspecificity of the test 
indicated a measure of anti-lung tissue response. 
In another report, Roberts and Little (1970b) investigated the 
possibility of auto-immune response associated with mycoplasmal pneumonia 
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of swine. They used a heated extract of norma 1 P.i g 1 u.ng as a .CF anti gen. 
They titered 400 serum samples against both ·the lung extract and the 
!1· hyopneumoni ae ant.i gen. Complement-fixing antibodies .against the 
IJ1YCOplasma antigen and the lu.ng extract were demonstrated. Serum samples 
which reacted positively against Ji. hyopneumoniae also gave similar positive 
reactions with the 1 ung extract. These preliminary findings suggested to 
the authors that an auto-immune phenomenon might be involved. 
Slavik (1g71) and Slavik and Switzer (1972) have developed a workable 
modified di re ct mi croti trati on comp l ement-fi xati on test for the diagnosis 
of !1· hyopneumoniae. Test serums were heat-inactivated at 54°C to 56°C for 
30 niinutes in order to destroy the natural hemolysins in P.ig serum. The 
lyophil i zed. guinea-pig complement was reconstituted with fresh, norma 1 
serum from young, pneumonia-free pi gs. This modi fi ca ti on had the double 
effect of compensating for the procomplementary activity of swine serum on 
- the. guinea-p.ig complement and of restori.ng or supplementing the complement-
bindi.ng capacity of the inactivated serum. The diagnostic CF antigen was 
prepared by diluting a 10% suspension cif the harvested organism to a 1% 
concentration, and then heating at s2°c for 30 minutes. This antigen was 
titered in the CF test against serum from a pig known to be infected with 
!1· hyopneumoniae. The CF test was performed in microtiter plates, 
according to the procedure outlined by the Laboratory Branch of ·Communi-
cable Disease Center (1965), except for the modifications indicated. The 
sensitivity of the t~st was markedly increased, as antibodies were 
detectable at dilutions of the test serums as low as 1:8. The modified CF 
test was used to diagnose 90% or more of Ji. hyopneumoni ae infections in 
pigs that had typical macroscopic lesions at necropsy. The sensitivity 
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of the test was evaluated by testing l'.1· hyopneumoniae, M. hyorhinis, and 
M. hyosynovi ae anti gens against the. heterol ogous and homo l.ogous antiserums. 
No cross-reactions were demonstrated. 
In a recent discussion, Switzer (1972) has outlined the essential 
elements and the advantages of this modified complement-fixati6n test. 
Immunization against Mycoplasma Infections· in 
Humans and in Animal Species 
Contagious bovine pleuropneumonia · (CBPP) · 
Before the introduction of the modern program of vaccination against 
contagious bovine pleuropneumonia, native cattle owners in Africa were 
using a modification of Willem's method of rubbing infected pleural lymph. 
into an incision made over the nasal bones (Lindley, 1965). Current field 
immunization against CBPP is carried out almost exclusively with attenuated 
live vaccines; the data on the value of inactivated vaccines are fragmen-
tary and conflicting. 
Walker (1921, 1922) recorded that the virulence of the etiologic 
agent, Mycoplasma mycoides var. mycoides, diminished as a result of serial 
passage in artificial medium. He demonstrated th.at by the 27th passage 
the agent became attenuated; he subsequently developed a "culture-virus" 
technique for protective i nocul at ion. The attenuated vaccine was 
inoculated into the tail. Animals that showed no reaction to the vaccina-
tion were then injected in the shoulder, and if this still failed to elicit 
a reaction, a third inoculation was given. During this time the belief was 
that immunity would result only when a visible or palpable local reaction 
occurred, and it was necessary to continue the ·inoculation until such a 
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reaction w_as ,induced. . .. 
Benneth (l9J2(shoW~a that 0i111ll~nity could be induce~ragai.~sf CBPP ' 
wi th9ut the producti_on _of . the visible or palpable reaction:: He advocated _ ·
_ a single inoculation method for the nomadic Sudan herds. 
.. . . , ' . . ' ' 
Purchase .(1939) tested the antigenicity of attenuated- live vaccine " 
i' ' 
derived from the 11th to 45th pass.age of the "cul tu re-virus" on two local 
breeds of cattle in Kenya. Groups of cattle were_ given one, two, or three 
doses of the vaccine. The first inoculation was made in the tip of the 
tail .and subsequent inoculations were. given subcutaneously in the shoulae'r. 
Vaccinated •cattle .:were· challirnged ,by contact-exposure to known infected 
herds or by subcutaneous injection--of fresh, nonattenuated culture .. .- Local 
reactions :to the-vaccination were.mild. A stro.ng inmunity was-induced in 
- ' ' 
_one .breed Of cattle but only 30 to 60% of the second breed were protected. 
The immunity was induced sooner when the number of doses of vaccine was . , ' . 
increased. The author recommended, therefore, that for -field. vacCi.nation; 
two doses of the vaccine be given at 21 days interval. 
• ' L • ' 
·Priestley' (l955a,b) reported that f~eeze-dried pleuropneuinonia 
()rganisms reconstit.uted in. saline or broth failed to elicit immunity oh 
iriJection into: cattle. When the- reconstituted susp~rision.was mlxeq with 
a~ equal volume of l% _agar in saline and then injected, solid immunity was 
readily and rapidly produced. The vaccine was. prepared _from a suitably . . ' . 
attenuated strain obtained .after the 12th serial pass.age and inoculation_ . . . . 
was made in tlie tail. Protective illlllunity.was tested· by intramus~ula_r 
challenge 28 days after. vaccinati_on. When· agar was used as the. adjuvant, · . . . . 
the. number of o.rganisms required to immunize was very much -smaller. For 
field ilitnuni·zati,oh·~ .. tft:~:-:~uthlir r~commehcfoc( a.· do~age·'of\0:2rnr con't~i'~i)1g .• > . 
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10,000 viable o_rganisms. He also invest_igated the adjuvant action of hens 
_e_gg. Whole .e.gg, and especially yolk, was found to be a. good adjuvant, 
but not as. good as .agar. 
Dafaalla (1956) investigated the adjuvant effect of 16 substances 
with the hope of finding some simple substitute for agar. Four classes of 
substances were tested with the dried CBPP vaccine of Priestley (1955): 
mineral salts, polysaccharides, peptone and proteins, and oils. Groups of 
serol.ogically n_egative cattle were inoculated at the tail-tip with 0.2ml 
doses of the adjuvant~contai ni ng vaccines, and were cha 11 enged by intra-
muscul ar injection of the virulent culture. Six mineral salts, 
polysaccharides (starch and. gum acacia), bovine. gamma globulin, and sesame 
oil were ineffective as adjuvants, as specific immunity could not be 
detected. Bovine albumin, liquid paraffin, and mucin gave encouraging 
results; two of each group of 3 animals inoculated with vaccines containing 
these substances developed antibodies and resistance to challenge. Of 24 
animals vaccinated with organisms in Shell ondina oil, 16 developed anti-
body and 17 resisted challe.nge. 
Hyslop (1956) studied the duration of immunity in cattle vaccinated 
with egg-adapted ( avi ani zed) CBPP vaccine. At one month after vaccination 
none of the vaccinated animals reacted severely to subcutaneous challenge. 
In the. group challe.nged at 14 months post-vaccination, only one of 7 
reacted severely. Twenty-two months after vaccination, 2 of 10 vaccinates 
reacted severely. By the 43rd month. post-vaccination, the number of 
severe reactors in the vaccinated. group had increased to 6 out of 12. The 
increasing proportion of severe local reactors showed a decline in 
resistance during three and one half years. None of the vaccinated cattle 
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died, while 9 ~f 19 control ani~als died. 
In view of the field evidence that highly attenuated avianized CBPP 
vaccines sometimes failed to stimulate protective immunity, Piercy arid 
Knight (1958) carried out trials with vaccines prepared from o.rganisms at 
differing levels of .egg pass.age. Three of the 6 batches of vaccines were 
prepared from the 44th e.gg-passage of T1 strain culture; the other 3 
batches were prepared from the 137.th, 162nd, and 185th .e.gg-pass.age levels 
of the same strain. All the vaccines conferred a significant d.egree of 
protection, altho.ugh not complete immunity. The increased passage through 
eggs did not lessen immunizi.ng ability, since results at passage 185 were 
apparently better than at pass.age 44. 
Hudson and Turner (1963) compared the efficacy of two types of 
Australian· vaccine: the standard laboratory culture vaccine and the 
avianized vaccine. The culture vaccine was prepared from the 21st passage 
of !1· OJYCOides strain V5; the·avianized vaccine was prepared from 
lyophilized material made from the 6th e.gg-passage of the same strain. 
Sero 1 ogi ca lly n.egati ve cattle were vaccinated in the tail-tip, and were 
then challenged by contact exposure to other cattle infected by intra-
bronchial intubation with a virulent strain of J1. rnycoides. Groups of 
vaccinated cattle were challenged at 1 week, 1 month, .3 months, and 12 
months post-vaccination. The number and severity of local reactions to 
vaccination was greater in the .egg-vaccine. group than in the broth vaccine 
group. Egg-vaccine produced almost complete protection against challenge . . . 
exposure as early as one week after vaccination. Although the response to 
broth vaccine was slower, there was little difference between the efficacy 
of the two vaccines when challenge was made 1 or 12 months after vaccination. 
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Lindley (1965) showed that an avirulent or attenuated strain KH3J of 
M. mycoides was a. good immunizing _agent when administered as a broth 
culture vaccine into N_igerian Zebu cattle. At varyi_ng periods after 
subcutaneous vaccination with fresh culture vaccine the animals were 
. challenged by subcutaneous injections of lyophilized virulent strain. 
Thirty-one of 37 vaccinated cattle were resistant to challenge. In- another 
trial, the author reported that l % _agar had an i ns_i gni fi cant adjuvant 
effect when added to the lyophilized vaccine. This was in contrast to the 
results reported by Priestley (1955a,b). This investigator reasoned that 
the conflict was due to differences in the strain; the more virulent the 
strain, the more pronounced the effect of adjuvant. 
Hudson (1965) evaluated the immunizing value, in Australian cattle, 
of the attenuated KH3J strain obtained from Nigeria. He compared two. 
groups of cattle vaccinated either in the tail-tip or subcutaneously 
behind the shoulder with the same dose of the same strain. There was an 
indication that tail-tip vaccination was more effective; there was no 
detectable local reaction and no evidence of lu.ng lesions. The trial also 
demonstrated that the attenuated KH3J vaccine produced a level of immunity 
about equal to that induced by the strain VS broth vaccine. 
Lloyd (1967) investigated the role of humeral antibodies in resistance 
to!'.!_. mycoides infection by passive transfer of immune serum. Serums, 
obtained from immune cattle that had· resisted the local infection, were 
administered to susceptible cattle. These passively inoculated animals, 
together with the immune serum donors and nonimmunized controls, were 
challenged by subcutaneous i no cul ati on with virulent strain of the 
organism. None of the immune-serum donors showed a local reaction to the 
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challe.nge injection. In contrast, all the cattle that received the inmune 
serum as well as the controls developed characteristic Willem's reaction 
(severe local inflammatory swelli.ng, edema, and necrosis). These results 
indicated that while active immunization produced resistance to 
re-infection, passively transferred immune serum was unable to provide 
protective inmunity. The authors suggested that resistance of immune 
cattle to contagious bovine pleuropneumonia may depend very little, or 
not at all, on humeral antibodies. 
Davies (1969) investigated the persistence of M. l!JYCoides in the host 
following vaccination with live T1 broth vaccine. Cattle were vaccinated 
in the tail-tip and were slaughtered at intervals to determine the spread 
of the inmunizi.ng o.rganism. The organism was recovered only from the site 
of vaccination and the regional lymph nodes draining the site. Isolations 
were successful for only 14 days post-vaccination. 
Gilbert et _tl. (1970) tested the effectiveness of the T1 strain broth 
vaccine by carrying out "in contact" challe.nge 6 and 12 months after a 
single primary vaccination. No CBPP lesions were seen and no isolations 
of!'.!· 11\YCOides were made from any of the cattle challe.nged 6 months after 
vaccination; all controls developed lesions from which the organism was 
isolated. In the cattle challenged 12 months post-vaccination, isolations 
were made from the respiratory tract of 3 of the vaccinates, although none 
of them developed CBPP lesions. This finding indicated that a single 
injection of the vaccine produced a high 1eve1 of inmuni ty for 6 months, 
but the protection was decreasing by 12 months. The authors recorrmended 
annual vaccination as a practical immunoprophylactic procedure. 
In Vom, N.igeria, Karst and Mitchell (1972) investigated the effect of · 
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intranasal vaccination of cattle with an attenuated Gladysdale strain of 
M. mycoides. The attenuation was carried out.by passaging the strain 20 
times in bovine kidney cell culture. When inoculated subcutaneously in 
more than 1000 cattle, the attenuated strain, G/20, did not produce any 
adverse effect. The strain was then passaged 10 times in cattle by 
intranasal instillation and it did not revert to virulence. The G/20 
. strain was used for the production of CBPP vaccine which was inoculated 
intranasally in 17 cattle. The vaccinates were challe.nged by contact 
exposure to cattle affected with CBPP. The vaccine had an efficacy of 77% 
when it was inoculated 24 hours before challenge, and of 83% when inoculated 
6 months befo.re challe.nge. 
Avian Mycoplasma infections 
Nelson was probably the first to demonstrate immunity to Chronic 
Respiratory Disease, an infection of chickens and turkeys caused by 
Mycoplasma gallisepticum (McMartin and Adler, 1961). He observe9 that 
chickens which·recovered from the chronic disease were resistant to a 
second exposure. 
Adler et _tl. (1960) also observed that recovery from the natural 
infection conferred measurable immunity in turkeys and chickens. They 
were unable to induce immunity with a vaccine prepared by sonic disruption 
of the organism. They also failed to immunize turkeys with a formalin-
inactivated vaccine. Aluminium hydroxide adjuvant did not influence the 
response. An attenuated live culture administered intramuscularly or 
intravenously conferred protection against the air-sac route of challenge 
i no cul at ion. 
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McMartin and Adler ( 1961) reported that birds .vaccinated i ntranasa lly 
with live M. ga 11 i septi cum were refractory to abdominal air-sac challenge 
inoculation. 
Domermuth (1962) reported that 38%_ of immature chicks vaccinated 
subcutaneously with a live culture of 11·. gallisepticum were immune to 
subsequent challenge by the air-sac route. Multiple vaccination of 
chickens with 11·. ga 11 i septi cum had no s i gni fi cant effect on either egg 
production or hatchability; the causative agent could not be cultured from 
the eggs of the vaccinated birds, and no evidence of immunity was detected 
in their progeny. 
Warren et.!)__. (1968) noted that intranasal or subcutaneous inoculation 
of formal i n-i nacti vated cul tu re vaccine of 11· gall i septi cum increased the 
resistance of 1-day old chicks to air-sac inoculation of the homologous 
strain. The increase in resistance was not accompanied by s_ignificant 
increase in IHA antibody level. These ,invest_igators also noted that the 
earlier failure of Adler et~· (1960) to obtain protection with an 
inactivated vaccine might be due to three factors: the destruction of the 
antigen by prolonged sonication (30 minutes), the higher concentration of 
formaldehyde used (0.5%), or the use of older chickens (6 to 7 weeks) in 
their trials. 
Adler and Lamas Da Silva (1970) compared the immunogenicity of 
inactivated and live M.·. gallisepticum vaccines; they also studied the 
effect of dosage and route of inoculation on the immune response. Chickens 
i no cul ated intravenously with killed organisms were partially protected 
against challenge. However, intranasal instillation of the thimerosal-
inacti vated vaccine did not pro vi de protection against ch all e_nge. 
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Intranasal inoculation of live vaccine induced a high d.egree of immunity 
to both air-sac and intravenous challe.nge. The resistance appeared to be 
inmuni zi.ng-dose dependent; 1 esser numbers of o.rgani sms apparently provided 
little protection against severe challe.nge. There was sl.ight correlation 
between serol.ogic (HA) titer and inmune response, after intranasal 
vaccination. 
Few extensive studies have been reported on immunity to fllycoplasma 
synoviae, the etiologic agent of Infectious Synovitis. Wichmann et al. --
(1960) inoculated chickens with attenuated culture of _!i: synoviae, strain 
C-l. The birds were protected against footpad challenge with virulent 
cultures. Inmunity varied from complete resistance to resistance against 
systemic infection and death; synovial lesions were less extensive in 
partially protected birds. 
Carn.aghan ( 1962) demonstrated that birds recovered from experimenta 1 
.infection with M. synoviae developed stro.ng immunity .against challe.nge. 
Chickens that were infected by the footpad with strains maintained by 
serial egg-pass.age, developed typical lesions. The surviving birds were 
challenged-by intravenous inoculation, 39 days after infection. No 
systemic reaction or fresh lesions developed in the recovered birds. 
Passive inmunity was also demonstrated by intramuscular inoculation of 
susceptible chickens with serum from convalescent fowls collected 12 and 
16 weeks after infection. 
Olson et~- (1964) infected chickens with M. synoviae administered 
by the intranasal route. Four weeks later, some of the birds were killed 
and histol.ogic lesions were demonstrated. The surviving birds were then 
challenged in the footpad and were found to be refractory to challenge. 
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Vlaovic and B.igland (197.l·) reported an attempted immunization of 
turkey hens .against Mycoplasma meleagridis, the etiol.og1c .agent of 
Airsacculitis. Female turkeys were given five weekly injections of the 
live organism, starting 10 days prior to collection of .e.ggs. The inocula-
tions failed to induce any immunity or reduce the rate of e.gg transmission 
of the infective agent. The attempted immunization proved detrimental, as 
the progeny of the vaccinated turkey hens showed a higher incidence of 
more severe air-sac lesions than were observed in the controls. 
Human primary atypi_cal pneumonia 
The capacity of M. pneumoniae to produce characteristic disease in 
experimental animal models has led to some imaginative investigations 
directed toward the development of attenuated live vaccines. However, 
attempts to develop inactivated vaccines against !'.1· pneumoniae infection 
in man have been more successful. 
Jensen et~· (1965) prepared a formalin-inactivated vaccine from a 
M. pneumoniae strain adapted in a chemically defined medium. Hamsters 
intramuscularly inoculated with O.Sml of the inactivated vaccine developed 
resistance to intranasal challe_nge. Human volunteers who received intra-
muscular injection of the vaccine developed no adverse 1 ocal reactions. 
No challenge inoculation or evaluation of resistance in the vaccinated 
human subjects was done. 
Smith et~· (1967) evaluated the protective value of an inactivated 
M. pneumoniae vaccine in volunteers. The vaccine was prepared from 
M. pneumoniae grown in chloroform egg-yolk extract medium and was 
inactivated with formalin. Volunteers were given O.Sml of the vaccine 
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intramuscularly with a booster injection 5 .weeks later. They were then 
challe.nged with a live suspension of the o.rganism. Only one of 10 
volunteers with vaccine-induced anti body became ill, whereas 7 of 9 who 
failed to respond serologically developed definite respiratory tract 
disease. Vaccinated subjects who did not produce detectable serum antibody 
developed more severe disease than nonvaccinated subjects. These findings 
suggested that the inactivated vaccine had a protective effect. in those 
volunteers with vaccine-induced antibody, while the serologically 
nonresponding individuals might have been sensitized. The investigators 
. .· . . ~-
could not determine whether the protection was a function of the serum 
antibody. 
I 
Mogabgab (1968) described a formalin-inactivated vaccine in which 
M. pneumoniae was. grown in a "serum free" medium. When administered 
intramuscularly with alum adjuvant, the vaccine produced a 45% reduction 
of 11\YCoplasmal pneumonia in a population of approximately 21,000 military 
personnel. 
Fernald (1969) compared the antibody production stimulated by intra-
nasal infection of hamsters with that which followed parenteral immuniza-
tion with killed J:1. pneumoniae vaccine. Both intranasally infected and 
actively immunized hamsters developed serum antibodies, but the parenterally 
immunized. group developed higher circulating antibody titers. Among the 
animals that were previously infected but recovered and then were 
challenged, no pneumonia developed. In the. group that was actively 
immunized, all were infected on challenge and developed pneumonia in spite 
of the h.i gh serum anti body titers. This finding demonstrated a lack of 
correlation between serum antibody and resistance. The studies also 
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suggested that local antibody, either humeral or cellular, or both may be 
involved in resistance to !1_. pneumoniae respiratory infections. 
Lipman et ~· ( 1969) derived 3 different virulent and avi rul ent 
M. pneumoniae strains by serial passage of parent stra.ins in artificial 
medium or in hamsters. The 3 strains were characterized in an effort to 
determine the factors associated with virulence. The avirulent strain 
derived after 169 passages had lost both the ability to produce pneumonia 
in hamsters and the capacity to adsorb to erythrocytes (cytoadsorption). The 
loss of hemoadsorption accompanied with total loss of virulence suggested 
that cytoadsorpti on is a ·requisite for virulence. This finding indicated 
the possible use of the. avirulent strain in the production of live vaccines. 
Fernald and Clyde (1g70) investigated the influence of route of 
vaccination and of the virulence of mycoplasma strains on the induction of 
immunity against intranasal challenge with !1_. pneumoniae. Intranasal 
immunization with virulent strains of M. pneumoniae yielded a. 71% reduction 
in pneumonia in the population. Despite high level of serum antibody, 
intraperitoneal and subcutaneous immunizations with the same virulent 
strains produced only 61 % and 56% reductions, respectively. When th.e 
attenuated strain was used, resistance to pneumonia resulted after intra-
nasal immunization but not after parenteral vaccination. This finding 
demonstrated that serum anti body 1eve1 s .did not corre 1 ate with protection 
and that the route of vaccination was an important factor in immune 
response to!'.!.· pneumoniae. The investigators demonstrated growth-
inhibiting activity in bronchial washings of challenged hamsters. This 
suggested the induction of a local antibody response. 
Steinberg et~· (1971) employed genetic selection to develop 
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temperature sensitive.mutants of ['1. pneumoniae strains which could be used 
as live vaccines. They produced 14 temperature-sensitive (ts) mutants by 
expos i.ng the o.rgani sms to N-methyl-N-ni tro-N-ni tros.oguani dine (NTG). The 
ts mutants were able to. grow at 32°C, the temperature of the human upper 
respiratory tract. Their in vitro replication was impaired at 37°C, the 
·normal temperature of the human lower respiratory tract. Hamsters infected 
intranasally with the ts mutants did not develop pneumonia, whereas 64% 
of animals inoculated with the parent strain developed lung lesions. This 
was an indication that the ts mutants were unable to invade the lungs. 
Infection with the ts mutants induced definite resistance to challenge. 
The authors noted that the application, in humans, of these ts mutants to 
stimulate resistance will depend on the ability of such mutants to grow 
and stimulate effective immunity in the upper respiratory but not in the 
lower respiratory tract of man. 
Fernald (1972) investigated the role of cell-mediated immunity in 
human 111Ycoplasmal pneumonia by use of the technique of stimulation of 
peripheral lymphocytes in ·volunteers with natural ['1. pneumoniae infection. 
Lymphocytes were collected from the peripheral blood of donors· and were 
stimulated by treatment with phytohemagglutinin (PHA-P) and specific 
['1. pneumoniae antigen. Lymphocyte stimulation was determined by the 
incorporation of tritiated-thymine in cultures derived from the peripheral 
cells·. Cellular transformation occurred in nearly all individuals with 
confirmed M. pneumoniae infection who had specific antibodies. No such 
cellular reactivity was demonstrated in serol.ogically negative subjects. 
The specific reactivity of peripheral lymphocytes persisted for years. 
This observation s.u.ggested that a population of antigen-sensitive 
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lymphocytes remained in the circulation followfog naturally acquired 
infection. The study also suggested that immunity to M. pneumoniae 
infection is mediated by ci rcul ati,ng sma 11 lymphocytes. 
Swine mycoplasmal pneumonia 
Betts, Whittlestone and Beveridge (1955) indicated there was no field 
evidence that a natural infection of enzootic pneumonia induced any 
significant degree of immunity. 
Lannek and Bornfors (1957) showed, however, that pigs which had 
recovered from experimentally produced enzooti c pneumonia deve 1 oped a 
strong immunity to subsequent cha 11 enge. The pi gs were infected i nt.ra-
nasa l ly with a pneumonic lung suspension and the presence or absence of 
pneumonia was judged by X-ray examinations. By 11 B days post-infection 
the pigs had recovered (as determined by radiological examination). They 
were then challenged by a second inoculation or by contact-exposure to 
pneumonic pen-mates. All the challenged pigs were free·from lesions· of 
the disease at slaughter; in contrast, all control a·nimals with no previous 
exposure developed pneumonia. 
In another experiment, Bornfors and Lannek (1958) tested the ability 
of the same infectious strain to induce immunity (1) by intranasal 
i no cul ati on of pi gs which were receiving prophylactic doses of tetra-. 
cyclines, and (2) by repeated ·intramuscular injections of plieumonic lung. 
Pigs that were inoculated intranasally at the time they were on feeds 
containing tetracycline and that did not develop pneumonia during the 
3-week period of antibiotic treatment were challenged with. the infectious 
material after removal from the antibiotic treatment. Almost all the 
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1 ' • , .• '• ' ' • ,': • ( . ' • "' .• -
animals whic;h. had beeri 'effectively: protected by tetracycline treatment · 
•. ~ ~ '· ;_.- .;· '. ·. ', .. ·· .·:_ " ' .-· . _· . .. ':··: _·· , .. · .. ·. ,· :: · ... 
developed· pneumonia ·followi.ng· the· chall!!.nge inoculation•: The -result 
;, 
demonstrated that While' tetracycline prevented the producticin Of pneumonic . 
• ' • ,v 
, , <_ •• • ' • •, : •,.'•,\ •,', "', I 
lesions, a primary_ fnfection of mycoplasmal pneumonia was essential for · 
the devel~pinent of' immunity. P_igs that were. gi vel) repeated :i,nt'r~riiu~tlil ar 
injection of the pneu~onic lu.ng suspension and subsequently i::ha-llenged 
intranasally, developed pneumonia. This suggested th.at intramuscular. 
.· . . . 
inoc:ulati ons of ·th.e pneumoiti c :agent did not induce .ill'SJluni ty·. 
' . . . 
In Sweden; Pfizer (1968) marketed a ti ssue .. culture-deri ved vaccine 
' . y, 
_against mycoplasmal: pneumonia of swine. The ·colllllerci·al. vac,cine -was 
formalin-inactivated.and contained aluminium hydroxide as an· adj4vant. 
The ma~ufacturers claimed_ the vaccine was capable of fre!!ing'p.igs· in. · · 
infected herds '"from the0 disease within, a few iuonths ·after vacc'iilation·,' T!Je 
• ' • ' ' • • • : ,. ) j_ • 
vaccfoe had'.been· prepared from a culture that was later identified as 
' 
M. hyorhinis. A n~mberof reports (L'Ecuyer, 1962;-Go~dwin, 1967;.Slavik, 
. . . 
·1971)- have 'shown· the: absence of .serologic cross:-reaction between· M. 
!:1.)1yorhi nis ~nd M: .h,Yopneumoni ae, · the cause .. of swine mycopl asmal pneiJmbni a; 
This. mak~s ·rt·.ra.ther ;ili:ffic'ult to unde'rstaiid th!!· str~n~t;~r;otect{v~~A~~~Tty ·. · .. 
. . . . ' : . . 
. ·claimed .. for 0,this commercial vaccine. · 
· .- Goodw~n et .tl• ('1969a) infected pigs by .intranasal inoculations of 
pneumoni c lung .suspensions. Sixteen weeks after the primary i nfecti oil; 
when it. wa~ :pres'~~d 'the pi gs had' recovered •. they challenged .·ih~ surv'i vors . . - ~ .. ,. 
with the saine strain', No lung lesions we~e observed wheri the animal~~ Were 
. ' . • . . ·.· . ' .· .-· ' , ,· ,/ ' 
killed 3, weeks after cha1le_nge. · These fi ndirigs su_ggested that· pi gs 
.. acquired stro.ng immunJty after recovery from infection withmy'coplasmal 
pneuinon.ia. · ... in:; the sarrili,:.Year :Goodwin· e.t. an:-. ( l969b>}::t'esteti''tt\i{ abii1 ity of. . . :· •':·.,· ,.'•",- -·-·:' ,- ''.,· .. - . . _. .. ·; .. ',·:· 
... 
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fonnalinized !1· hyopneumoniae vaccine to induce immunity in pigs. The 
pigs were vaccinated twice with antigen prepared from the "J" strain. 
The first i njecti ans were given intramuscularly or i ntradennally with 
.Freund's complete adjuvant, and the second injection.was given without 
adjuvant. The immune status of the pigs was tested by intranasal. challenge 
with doses of pneumonia lung suspensions. The vaccinated pigs showed no 
evidence of resistance to challenge inoculation. The authors noted a 
possibility that any immunity induced had been overwhelmed by the large 
dose of challenge inoculum (5ml of 1 :10 suspension of the pneumonic lung). 
When a lower challenge dose was used, some protection.occurred in 3 of the· 
vaccinated pigs. In another trial, they injected a pregnant sow twice 
with nonformalinized antigen without adjuvant. The saw's litter was 
subsequently exposed to infection at 7 days of age, after.they had suckled 
naturally from b.irth. The piglets were not protected against challenge 
inoculation. There was no correlation between the vaccine-induced serum 
antibody level and protective immunity. 
Lam (1970) and Lam and Switzer(l97lb) evaluated the ability of five 
vaccinal preparations of !1· hyopneumoniae to prevent the infection in 
swine. Vaccine A was prepared by ether extraction of a concentrated 
suspension of the organism and contained Freund's incomplete adjuvant. 
Vaccine B was also prepared from ether extract but was formalin-inactivated. 
Vaccine F was prepared by alternate freezing and thawing in a solidified 
carbon-dioxide-alcohol bath; it too contained incomplete adjuvant. 
Vaccine G was prepared by lysis with 2% sodium l auryl ·sulfate (SLS) 
followed by dialysis against ammonium sulfate and distilled water. The 
fifth vaccine, Vaccine H, was a· formal i n-i nacti vated broth culture. Four 
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of the vaccine preparations were administered intramuscularly to. groups of 
p_igs; the p_igs were vaccinated 3 times at one-week intervals. Vaccine H 
was administered intranasally to a fifth. group of p_igs on 3 consecutive 
days. All the vaccinated pigs and controls were challenged intranasally, 
two weeks after vaccination. None of the 4 pigs that received Vaccine A 
(ether extract with incomplete adjuvant) developed gross pneumonic 
lesions whereas all 4 nonvaccinated controls developed pneumonia; 5 of 8 
pi gs given the fonnal ini zed ether extract (Vaccine B) were protected whereas 
7 of 8 controls had pneumoni c lesions; Vaccine F (freeze-thawed) protected 
19 of 26 pigs while 19 of 23 controls had lesions; and the SLS-lysed . . . . . 
preparation (Vaccine G) protected 15 of 18 p_igs while 15 of 19 control pigs 
developed pneumonia. None of the i ntranasally vaccinated pi gs was 
·protected. The results indicated that intramuscular injection of the 
vaccine pr:eparati ons provided some protective· immunity. These findings are 
in contrast with the result reported by Goodwin et!}_. (1969b); it is 
possible that the ethe·r extraction, freezi_ng-thawi ng disruption, and SLS 
lysis of the M. hyopneumoniae ant_igen enhanced its immun_ogenicity. 
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MATERIALS AND METHODS 
Source of Mycoplasma hyopneumoniae 
My cop 1 asma hyopneumoni ae strain #11 was used throughout this .study. 
L' Ecuyer ( 1962) originally obtained transmission of pneumonia in pi gs he 
inoculated with pneumonic lung material from. a pig in a large swini;! herd 
with chronic pneumonia. He obtained the infectious material from the 
eleventh herd he studied and therefore identified it as number eleven. 
When inoculated intranasally into respirator,y disease-free pigs, the 
pneumonic lung suspension consistently induced clearly demarcated, reddish-
grey pneumonic ]es ions,' frequently confined to the apical,· cardiac, and 
intermediate lobes of the lungs. The lesion was characterized.by 
perivascular and peribronchiolar lymphoid hyperplasia, alveolar interstitial 
thickening, and a 1veo1 ar exudation of neutrophi ls, lymphocytes and septa 1 
cells. The organism was serially passaged several times in the pig 
"(L'Ecuyer, 1962) and was grown in cell-free medium (Mar~. 1965). Mar~ 
and Switzer (1965) characterized the infectious agent and named it Mycoplasma 
hyopneumoni ae. Huhn ( 1969) has given a detailed diagrammatic passage 
history of the swine pneumonia organism. 
Broth passaged cultures of !1_. hyopneumoniae strain derived from a 
lyophilized culture of the 20th passage were employed in the vaccine 
production and in most experimental inoculations in the present study .. 
Growth Medium for M. hyopneumoniae 
Li gui d medium 
The cell-free medium for the propagation of !1_. hyopneumoniae 
consisted of Eagle's Minimum Essential medium, Hepes-Buffer 
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(N-2-hydroxyethyl piperazine-N-2 ethane sulfonic acid}, yeast extract, 
lactalbumin hydrolysate, and swine serum (Switzer, 1972). The medium 
contained the .following ingredients: 
, A. Eagl~'s Minimum Essential Medium1 
B. Hepes buffer (N-2-hydroxyethyl . pi perazi ne-N-2 ethane sul foni c 
acid) 2 
C. Yeast Extract 
a. Two-hundred and fifty grams Fleischl]lan' s type 20-403 dry 
yeast were added to 1 liter distilled water. 
b. The mixture was heated to boiling, with frequent stirring. 
c. The mixture was then filtered through two sheets· of Whatman #1 
filter paper. 
d. The pH was adjusted to 8.0, with lN NaOH. 
e. The yeast extract was dispensed in 5 to 8ml a 1 iquots, auto-
claved at 251°F (15 pounds pressure) for 15 minutes. 
f. It was stored at ~2o0c until used. Only the clear supernatant 
was used in the medium. 
D. Lactalbumin hydrolysate (enzymatic) 4· 
E. Swine serum 
a. Swine serum was adjusted to a pH of between 4.3· and 4.5 with 
lN HCl and was allowed to stand at 4°c for 2 to-18 hours. 
1Grand Island Biological Co., Grand Island, New York. 
2Nutritional Biochemicals Corporation, Cleveland, Ohio. 
3 Standard Brands Incorporated, New York, New York. 
4Nutritional Bioch_emicals Corporation, Cleveland, Ohio. 
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b. This acid-precipitated swine serum was then centrifuged at 
2000 rpm (590XG) for 15 minutes. The sediment was discarded 
and the supernatant was clarified thro.ugh a Whatman GF/a 
fiberglass filter pad and Selas #10, #01, #015, and #02 
porcelain filters. 1 
c. The pH was adjusted to 7.0 with lN NaOH, and the swine serum 
was stored at -20°C until used. 
The complete medium was prepared by mixfog the following components 
in the proportions indicated: 
1. E.agle's minimum essential medium 9.8gm 
2. Ion excha.nge column water lOOOml 
3. Hepes buffer 5.96gm 
4. Lactalbumin hydrolysate 10.0gm 
5. Yeast extract 10.0ml 
6. Swine serum 200.0ml 
The pH of the medium was adjusted to 7.6 with lN NaOH. The medium was 
clarified by passi,ng through Selas #10 and #01 filter candle, and 
sterilized thro.ugh a Se las #02 porcelain filter. The medium was dispensed 
in screw-capped. glass tubes ( 16 x l 25mm) or screw top fl asks and incubated 
at 37°c for 24 hours as a sterility check and stored at 4°c until used. 
Liquid medium used for the primary isolation of !1· hyopneumoniae from 
lung lesions contained thallium acetate and penicillin at a final concentra-
tion of 1:4000 and 1,000 units per ml respectively. 
Pike 
1selas Corporation of America. Fluid processing 
and Dreshertown Rd., Dresher, Pennsylvania. · 
division. Limekiln 
Solid medium 
A. Preparation of the agar 
1. Ion _Agar No. 21 
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3 .. 6gm 
2. Ion excha_nge column water 200ml 
The agar was added to the water in a lOOOml Erlenmeyer flask. The 
mixture was boiled in a water bath to dissolve the agar. The 
dissolved agar was sterilized at 121°C for ·15 minutes and then. 
allowed to cool to 45°c. 
B. Eagle's base (2x) medium: A 2x concentration of the complete 
Eagle's 1 i quid medium was fonriul ated accordi_ng to the following. 
procedure: 
1. Eagle's minimum essential medium 9.8gm 
2. Ion exchange water 500ml 
3. Hepes buffer 5.96gm 
4. Lactalbumin hydrolysate 10.0gm 
5. Yeast extract 10 .Oml 
6. Acid adjusted swine serum 70.0ml 
The pH. of the medium was adjusted to 7.6 with lN NaOH. Penicillin 
and thallium acetate were added to give a final concentration of 
1:1000 and 1:4000, respectively. The liquid medium was then 
clarified through Selas #10, #01, and #015 filters and sterilized 
thro.ugh a Se 1 as #02 fi 1 ter. 
C. The medium was bro.ught to the same temperature as the dissolved 
1colab Laboratories, Inc., Box 66, Chicago He.iglits, Illinois. 
I 
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agar (45°C) and the two were aseptically compined in equal parts. 
After mixing thoro_ughly and carefully by gentle swirling to. avoid 
bubble formation, the agar medium was poured into plastic petri 
dishes 1 and allowed to solidify. The plates were incubated at 
37°c for 24 hours for steri 1 i ty check and stored in p 1 as tic 
bags at 4°c. 
Maintenance of M. hyopneumoniae in Liquid Medium 
Screw-capped glass tubes containing approximately 6ml of complete 
Eagle's base medium were inoculated with O.Sml of~- hyopneumoniae fluid 
culture. Inoculated tubes were incubated at 37°c and serial transfers 
were made at intervals of 2 to 3 days. Selected passage levels were 
lyophilized in 0.2ml amounts and stored at -20°c. 
Growth of~- hyopneumoniae on Solid Medium 
Five-tenth ml of a 3-day olc! culture was inoculated onto the surface 
of agar plates. The plates were carefully rotated so the culture fluid 
evenly covered the agar surface. Inoculated plates were incubated in a 5% 
co2 incubator at 37°c, in an inverted position. The plates were examined 
daily for 5 to 6 days for M. hyopneumoniae colonies with the aid of lOOX 
magni fi ca ti on uti l i z;n·g a compound light microscope. 
Experimental Swine 
All the experimental pigs were obtained from the respiratory disease-
free herd maintained at the Veterinary Medical Research Institute, 
1Falcon Plastics, Division of B-D Laboratories, Inc., Los ·Angeles, 
California. 
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Iowa State University. The original stock was established from surgically 
derived pigs and has been maintained in quarantine for 20 years. The pigs 
were housed in isolation units duri.ng the experiments. All the pigs.were 
either Yorks hi res or Hampshi res and were 4 to 24 weeks of age at. the 
beginning of the experiments. They were fed a contract bid formulated 
pig grower ration of 19% protein that did not contain any added anti-
biotics. 
Infection of Experimental Pigs 
Pigs were exposed to !1· hyopneumoniae by intranasal instillation of 
3-day old fluid culture, or .of pneumonic lu.ng suspension, depending on the 
experiment. Each pig was given 5inl of the inoculum. The snout of the pig 
was held in an upright position and the nozzle of the syringe (without 
needle) was inserted into the nare. The culture was then insfilled 
slowly; instillation of a small amount of inoculum was synchronized with 
the inspiration of the pig. The pigs could be observed to swallow much of 
the inoculum. The inoculum was administered daily for three consecutive 
days. The pi gs were kept under observation for a varying nuniber of weeks, · 
as determined by the particular experiment. 
Necropsy Examination 
At the termination .of each experiment, P.igs were killed by electrocu-
tion and exsa.nguination, and necropsy was performed. The 1 u.ngs were · 
examined for gross mycoplasmal pneumonia lesions and lung specimens were 
taken for histological study. When desired, portions of pneumonic lungs 
were collected aseptically for isolation of M. hyopneumoniae. 
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Preparation of Lu.ng Tissues for 
Histological Examination 
Portions of the 1 ungs were fixed in 10% forma 1 in immediately after 
death. After 3 days fixation, the specimens were trimmed and embedded· in 
Paraplast1 tissue-embedding medium. They were sectioned at six .micrometers· 
and mounted on glass slides with an albumin fixative. Sections were then 
stained with Harris' hematoxylin and counterstained with eosin Y (U.S. 
Armed Forces Institute of Pathology, 1960). 2 
Isolation of Ji. hyopneumoniae from Pneumonic Lesions 
A portion of the aseptically co 11 ec:ted pneumoni c 1 ung was ground in a 
TenBroeck grinder, in the presence of about lOml sterile complete Eagle's 
medium containing peni ci 11 in ( 1000 1 U/ml} and tha.11 i um acetate ( 1 : 4000 
final concentration). Five-fold serial dilutions of the lung homogenate 
were made in screw-capped tubes containing Eagle's base medium with 
i nhi bi tors. Inoculated tubes. were incubated at 37°C. Ini ti a 1 passages 
from the primary dilutions were made at 4 to 14 days; subsequent passages 
were made at 3 to 5 day intervals. An inoculated tube was considered 
negative for Ji. hyopneumoni ae if growth could not be demonstrate.d after 14 
days incubation. A presumptive positive isolation was indicated by the 
following factors: an acid pH change and an increased opales~ence or 
turbidity to the medium; presence of a slight sediment which formed a 
delicate spiral when the tube was gently swirled; demonstration of typical 
1
sherwood Medical Industries, Inc., St. Louis, Missouri. 
2sectioning, mounting, and staining done by Pathology Laboratory, 
VMRI. 
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mycoplasmal elements in a Giemsa stained film prepared from the sediment 
obtained after centrifugation of the fluid culture; the absence of growth 
on 5% horse blood agar or in NIH thioglycolate broth;1 lack of growth in 
beef-heart-infusion-turkey serum1 plates. Confirmation of isolation was 
made by inoculation of Eagle's base agar plates with the fluid subcultures 
and by comparison of the colonial morphology of the isolate with colonies 
formed by the 1 aboratory-mai ntai ned !'.!· hyopneumoni ae. 
B 1 ood Collections 
Throughout the course of the experiments, blood samples were collected 
from the anterior vena cava of the pigs. Collected blood was allowed to 
clot for 1 hour at room temperature or was left. overnight at 4°c. The 
blood sample was then centrifuged at 1700 rpm (600 x G) for 10 minutes. 
The resulting serum was aspirated and stored at -ao0 c until ·-used in the 
serologic test. 
Production of!'.!· hyopneumoniae Vaccine and 
Complement-Fixation Test Antigen 
The fo 11 owing procedures were foll owed in the producti.on of immunizing 
vaccines and complement-fixation (CF) antigen. 
1. Five mililiter of a 48-hour high passage (greater than 200) fluid 
culture of M. hyopneumoniae was used to inoculate 250ml of sterile complete 
Eagle's base medium in a SOOml screw-capped flask. The inoculated flask 
1Difco Laboratories, Detroit, Michigan. 
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was incubated at 37°c for 3 days and the culture was then mixed with equal 
parts of a sterile 24% sucrose solution and dispensed aseptically in 5ml .. 
amounts into sterile screw-cap tubes. The tubes were stored at -so0c. 
2. Appropriate numbers of the frozen cul tu re tubes were thawed and 
each 5ml of culture was inoculated into a screw-capped 1-liter flask 
containing approximately 500ml of sterile Eagle's base medium .. The fiasks 
were incubated for 3 days at 37°c in a shaking waterbath; the shaker was 
set at 10 to 15 oscillations per minute. This gentle shaking was found to 
be an important factor in production of a high titer antigen. An 
accelerated rate of agitation of the flasks caused precipitation of serum 
proteins from the culture medium, while stationary incubation resulted in 
low antigen yields. 
3. Antigen was harvested by centrifugation of·the culture at 12,000 
rpm (.15 ,000 x G) at 4°c for 30 minutes in a Beckman Model L-2-65 (Head #19) 
preparative ultracentrifuge. The sediment was resuspended in veronal 
buffered diluent without ~elatin (see subsequent section for composition) 
to 2% of the original volume of incubated medium. The suspension was 
washed two times by centrifugation at 2,500 rpm (1300 x G) for 45 minutes· 
in l5ml centrifuge tubes. The packed mycoplasma was reconstituted to a 
10% concentration with veronal buffered .diluent. Usually, 0.5 to 0.75ml 
of packed mycoplasma was obtained from 1500ml of inoculated medium. The 
10% suspension was then dispensed in vials in lml quantities and stored at 
-so0 c until used as CF antigen or as vaccine. 
4. Growth Initiating Titer was determined for each lot of. 
M. hyopneumoniae antigen or vaccine produced. Before the culture was 
harvested, Sml of the incubated flask culture was .aseptically aspirated. 
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Five-tenths ml of this culture was inoculated into 4.5ml of sterile Eagle's 
mediuni in a screw-cap tube and the serial ten-fold dilution was continued 
until a final dilution of 10-10 of the original culture resulted. 
Inoculated tubes were incubated at 37°C for 7 to 10 days and were checked 
daily for growth of .!i· hyopneumoni ae. The highest di 1 ution in which growth 
occurred was recorded and the reciprocal of that dilution marked the growth 
initiating titer. A growth initiating titer of 10-6 or more in·the flask 
culture was considered satisfactory. 
5. The pH of the incubated flask culture was determined before the 
anUgen was harvested. Fifteen to 20ml of the culture was transferred into 
a 50ml beaker and the pH was read with the aid of a pH meter. 
6. Checks of the flask cultures for bacterial contamination were made 
by inoculati.ng 0.25ml of the culture onto blood agar plates and into 
thioglycolate broth. Beef-heart-infusion-turkey serum plates were also 
inoculated with 0.5ml of the culture to check for other mycoplasmal 
contamination. The inoculated plates and broth were incubated at 37°c and 
examined daily for any indication of growth. The flask culture was regarded 
as n.egative for contaminants if no growth was observed on the plates or in 
the broth after 5 days of incubation. 
Complement-Fixation Test 
Serum samples were tested for the presence of specific antibodies 
against .!i· hyopneumoniae by the modified direct microtitration complement-
1 .. . 
fixation (CF) test:. The CF tests were conducted according to the modified 
1
The CF tests were performed by M. F. Slavik, Veterinary Medical 
Research Institute. 
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technique developed by Slavik ( 1971). The preparation of the re.agents, the 
titration of complement, hemolysin, and ant,igen, and the procedure for the 
diagnostic test are briefly outlined. 
Veronal buffered diluent (VBD) with gelatin 
A 5X stock solution was prepared by combini.ng the followi.ng components 
in a 2 liter volumetric flask in the order listed: 
NaCl 
Na-5, 5-diethyl barbiturate 
Distilled water 
lN HCl 
Stock solution containi,ng 1 molar 
.MgC1 2 and 0.3 molar CaC1 2 (20 .. 3gm 
MgC1 2 ·6H20 and 4.4gm CaC1 2·2H20 in 
lOOml distilled water) 
83.00gm 
10.19gm 
500.00ml 
30.00ml 
5.00ml 
The flask was filled to the mark with distilled water and the i.ngredients 
were mixed thoro.ughly. One hundred ml of 5X stock solution of VBD, 400ml 
of distilled water, and 16ml of 2.5% gelatin in distilled water.were mixed 
thoroughly in a. graduated cylinder. This solution made a lX concentration 
of VBD-with.-gelatin for daily use and was stored in l liter plastic bottle 
at 4°c. 
Sheep red. blood cells (RBC) suspension 
Five ml of.sheep blood, preserved in an equal volume of Alsever's 
solution (Karrer et~-, 1950) was added to lOml VBD with. gelatin and the 
mixture was centrifuged at 1700 rpm (600 x G) for 5 minutes. After removal 
of the supernatant and white cell layer (buffy coat) more VBD was added 
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to give a total volume of 15ml. The RBC were re-suspended and were 
washed two more times by centrifugation. Followi_ng the final wash, the 
supernatant was removed by aspiration and the volume of the packed cells 
was recorded. Thirty-four and seven-tenths volumes of VBD were added for 
each volume of packed sheep red blood cells; this made a 2.8% RBC suspen-
sion which was stored at 4°C and was used on the day of preparation. 
Hemolysin 
Glycerinated anti-sheep hemolysin1 was initially diluted to 1 :100 by 
mixing 0.2ml of the 50% hemolysin antiserum and 9.8ml of 0.85% saline. 
Titration of the hemolysin was perfonned as follows: Six dilutions from 
1:1000 to 1:8000 were made in VBD and lml of each hemolysin dilution was 
added to equal volume of 2.8% sheep RBC. The mixtures were incubated at 
37°C for 15 minutes. Two-tenth ml of the sensitized RBC (from each 
hemolysin-dilution) was mixed with 0.4ml of cold VBD and 0.4ml of comple-
ment. The mixtures were again incubated at 37°c in waterbath for 1 hour 
and then centrifuged for 5 minutes. The percentage of hemolysis was 
found by comparison with freshly prepared hem_ogl obi n co 1 or standards and 
the optimum dilution of hemolysin was detennined from the plotted linear 
. graph. 
Sensitization of red blood cells ---
One volume of "optimal" hemolysin dilution was added to. an equal 
volume of 2.8% sheep red blood cell suspension. The mixture was incubated 
1Difco Laboratories, Detroit, Michigan. 
I 
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at 37°c in a water bath for 15 minutes. This procedure was carried out 
just before the use of the sensitized cells in the final CF test. 
Guinea-pig complement 
Commercial lyophilized guinea-pig complement1 was used. The complement 
was modified by re cons ti tu ting it with fresh, normal serum from young, 
pneumonia-free pigs. The effects of this modification were a.compensation 
for the procomplementary.property of swine serum on the guinea-pig 
complement and the restoration of the complement-binding capacity of the 
inactivated test serum. Dilutions (l :400 and 1:500) of the reconstituted 
complement (C') were made in VBD plus gelatin. Each dilution of C' was 
ti tered by addfog varying amounts of a particular dilution to appropriate 
volumes of chilled VBD in 4 serol.ogic tubes. A constant volume of the 
sensitized RBC was added to each tube to. give total reaction volume of lml. 
The mixtures were incubated in a 37°c waterbath for 30 minutes and then 
centrifuged. The percent.age of hemolysis of each tube was found by 
comparison with a hemoglobin color standard. The C1 H50 (reciprocal of 
complement dilution producing 50% hemolysis) was determined by a 
logarithmic graphing method and the equivalent of five C1 H50 units (the 
working concentration in the CF test) was calculated a.lgebraically. 
Anti gen 
The diagnostic !1_. hyopneumoniae antigen was prepared by diluting the. 
l0% suspension of the harvested o.rganism (see above) to a 1% concentration, 
1Difco Laboratories, Detroit~ Michigan. 
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and then heating at s2°c for 30 minutes. The ant.i gen was then ti tered . . 
against a standard serum from a pig known to be infected with 
!:!· hyopneumoniae. Antigen titrations were cond.ucted in plastic micro-
titration plates 1 containing 96 LI-shaped wells. Diluti.ons were made with 
VBD plus gelatin. To each well containing the appropriate ant.igen and 
serum diluti.on, 0.05ml (5 C1 H50 units)" of the complement reconstituted 
with normal swine serum was added. The plates were shaken and incubated 
overnight at 4°c. Sensitized sheep RBC (0.025ml) was then added to each 
well; the plate was re-incubated at 37°c for 30 minutes. After centrifuga-
tion, the percentage of hemolysis in each well was determined. The 
antigen dilution that gave the. greatest fixati.on of complement (0 to 30% 
lys is) with the highest dilution of anti serum was taken as the working 
dilution for use in the diagnostic CF test. This working antigen dilution 
must, at the same time, show no anti-complementary effect. 
Antiserums 
Test serums were inactivated by heating· at 54°c to 56°c for .30. 
minutes. 
Procedure for complement fixation (CF) test 
The CF test was performed in microtiter plates. Into each well of 
the first row was added 0.05ml of the different heat-inactivated test 
serums. Veronal buffered diluent plus. gelatin (0.025ml) was dropped into 
all other wells. Two-fold dilutions of the serums were made and the plate 
1Linbro Chemical Company, Inc., New Haven, Connecticut. 
55 
was chi 11 ed at 4°c for 30 minutes. Twenty-five-thousandth ml of a work fog 
dilution of the antigen cooled to 4°C was added to each well; five units 
(0.05ml) of chilled complement was also added to each well. The plate 
was shaken and placed at 4°C for 15 to 18 .. hours. After this initial incuba-
tion, 0.025ml of the sensitized sheep RBC was added to all of the wells. 
The plate was re-incubated at 37°C for 30 minutes and then centrifuged at 
2500 rpm (1300xG) for 5 minutes. The percentage of hemolysis in each well 
was determined with the aid of a test reading mirror 1 and recorded. Test 
serums were considered positive if they showed 70% or more intact RBC 
(30% or less hemolysis) at serum dilutions of 1:8 or greater. Titers were 
expressed as reciprocal of the highest dilution of the test serum, that 
exhibited the 70% or more intact RBC. Controls of the appropriate 
·reagents were ·included in each CF test. 
Experimental Design 
Four separate immunization trials were conducted. The first trial 
was designed to evaluate the ability of a!'.!_. hyopneumoniae vaccine to 
eliminate lesions and promote recovery in pigs already infected with the 
organism·. The other three experiments were carried out to determine the 
ability lf !'.!_. hiopneumoni ae vaccines to pro vi de resistance to cha 11 enge 
infection. 
Following the persistent failure of the vaccinated and especially 
the nonvaccinated control pigs in one of t~e immunization trials to 
develop a serologi c response followfog challe.nge exposure, other · 
1cooke Engineering Company, Alexandria, Vi.rginia. 
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experiments were des.igned. One experiment was performed to evaluate both 
the virulence of the test organism and the effect of .age. of the experi-
mental swine on susceptibility to experimental mycoplasmal pneumonia.· 
Two experiments were conducted to investigate the presence in the. feed of 
a M. hyopneumoniae inhibiting substance. 
ll1111uni za ti on Trials · 
Experiment .!.. 
Six- to 8-week old pigs which had been naturally infected .with 
M. hyopneumoniae were tested serologically. Ten of those pigs that 
exhibited two consecutive positive CF a:nti body titers were chosen for the 
trial. By random selection the 10 pigs were assigned to two equal .groups. 
One group served as infected pi gs to be immunized and the other group 
served as infected but nonimmunized controls. The vaccinated and 
nonvaccinated groups were housed in separate isolation units. 
On· each day of immunization, the vaccine was prepared as follows: 
The frozen 10% concentration of!:)_. hyopneumoniae packed cells was thawed. 
An equal volume of incomplete Freund's adjuvant was added to each vial and 
a water-in-oil emulsion· was made by thoroughly mixing the contents with a 
syringe and 20 gauge needle. 
Ea.ch of the vaccinated pi gs was inoculated with lml of the adjuvant-
1 i ve vaccine mixture. Injections were by the subcutaneous route in the 
flank region. Pigs were vaccinated tliree times at one week intervals. 
Blood was collected each week from all the pigs. Complement-fixation 
tests of the serums were performed and the se.rol.ogic titers were recorded. 
At no other time during the ·course of the trial were these.pigs 
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reinfected or challe.nged by intranasal inoculation of !i· hyopneumoniae 
culture. Seven weeks after the last vaccination, all pigs were killed and 
I 
a necropsy was performed. The incidence and extent of gross pneumonic 
lesions were recorded. 
Experiment ll 
Two types of !i· hyopneumoniae vaccines were used in this trial. One 
of the vaccines was prepared from the 10% concentration of the harvested 
flask culture, as described in Experiment I. However, this vaccine was 
heat~inactivated at 52°C for 30 minutes. The vaccine contained equal 
parts of incomplete Freund's adjuvant and was des.ignated as Flask-antigen. 
The growth initiati.ng titer of the flask culture from which it was 
prepared was 10-7 prior to harvesting and concentration. The other vaccine 
was prepared from a 25% suspension of pneumonic lung obtained from pigs 
inoculated in previous research with !i· hyopneumoniae strain 11. The 
frozen lu.ng material was thawed and the suspension was reconstituted to a 
10% concentration with sterile Eagle's based.medium. The material was then 
thoroughly mixed with incomplete Freund's adjuvant. This vaccine was 
designated as Lung-ant.igen. 
Sixteen pigs, 3 to 4 weeks old, were used in the trial. All the pigs 
were sero 1 ogi cal ly n.egati ve to !i· hyopneumoni ae infection as determined by 
three complement-fixation tests performed at one week intervals. The 
anima 1 s were randomly assigned to 4 equa 1. groups: P.i gs to be immunized 
with the flask-antigen (Flask-antigen vaccinates); pigs to be vaccinated 
with the pneumoni c 1 ung preparation ( Lung-ant.i gen vaccinates); pi gs not 
immunized but later challenged (positive controls); and pigs not immunized 
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and not challenged (negative controls). The nonexposed negative control 
pigs remained in the supply herd until necropsy. The other 12 animals were 
housed in individual plexiglass cages in a large isolation unit. Two pigs 
were placed in each cage, thus making a duplicate of each experimental · 
group. One ml of the respective antigen was administered subcutaneously 
at the flank region to the appropriate·pigs. One week after the first 
vaccination, a booster inoculation w11s administered by the same route. A 
third inoculation was given two weeks afte.r the second inje.ction. Four 
weeks after the final i no cul ati on, all the vaccinated pi gs and the positive 
coritrol pigs were challenged by intranasal instillation with a low passage 
(passage 21) £i. hyopneumoniae fluid culture. The challenge inoculum had a 
growth initiating titer of 10- 7. Challenge inoculations were administered 
on three consecutive days. Blood was collected from the pigs each week 
and the serums were tested for antibodies against £i. hyopneumoni ae. Four 
weeks after the challenge all pigs were necropsied. Lung specimens were 
collected for histological examination. 
Experiment .!.!.!. 
This trial was designed to evaluate the cumulative effect of 
M. hyopneumoni ae vaccines administered by various routes in inducing 
resistance of swine to challenge infection with the organism. 
Twenty-four pneumonia-free (serologically n.egative) pigs consisting 
of equal numbers of vaccinates and nonvaccinates were used in the trial. 
The animals were housed in 3 isolation rooms, each room containing 4 
vaccinates and 4 nonvaccinates, randomly selected. Each of the vaccinates 
was inoculated by the subcutaneous, footpad, intraperitoneal, and 
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intratracheal routes. 
The vaccines consisted of a 10% suspension of M. hyopneumoniae 
ant_igen harvested from flask cultures. For the subcutaneous and footpad 
inmunizations, live vaccine containing equal volume of incomplete Freund's 
adjuvant was used. Intraperitoneal inoculation was also made with a live 
vaccine but no adjuvant was added. The vaccine for intratracheal inocula-
tion was .heat-inactivated in a waterbath at 52°C for 75 minutes; this 
vaccine contained no adjuvant. 
On the first day, each of the vaccinates in isolation units #3 and 
#21 was_ given subcutaneous and footpad inoculations. One ml of the 
adjuvant-containing vaccine was administered subcutaneously and 0.2 to 
0.3ml was administered into the footpad. Vaccinates in isolation unit #20 
received only the subcutaneous inoculation. On the 5th day, 40 to 50ml 
of mineral oil was administered i ntraperi tone ally into each vaccinate .. 
The mineral oil was administered to cause an accumulation of inmune-
responsive peritoneal macroph_ages. Six days after the administration of 
the mineral oil, all the vaccinates were intraperitoneally vaccinated with 
lml of vaccine. One week after. the intraperitoneal inmunization, the 
second subcutaneous and footpad inoculations were made; this time, th_e 
vaccinates in unit #20 also received the footpad injections. After 
another 7 days, all vaccinates were given an intratracheal inoculation of 
0.5ml of the heat-inactivated vaccine per pig. Two weeks after the 
intratracheal injection (six weeks after the first vaccination), all the 
vaccinates and nonvaccinates were challenged intranasally with low passages· 
(pass.age 29 to 31) of !:1_. h,Yopneumoniae fluid culture. Challe_nge inocula-
tions were administered on 3 consecutive days. The challenge culture had 
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growth initiati.ng titers of 10-5 to 10-6. Blood for serol_ogic tests was 
collected at regular intervals from the p_igs. Since five weeks after the 
challe.nge exposure to M. hyopneumoniae, none of the control animals had 
reacted serologically to the challe_nge, all the pigs were challenged _again. 
Both pneumoni c lung suspension and the laboratory-maintained high passage 
(p. 324) fluid culture were used in the second challenge. The high passage 
culture had a growth initiating titer of 10-8 . All the pigs were killed 
three weeks after the second challenge and necropsy was performed. 
Experiment 11 
The vaccine used in this trial was a 10% suspension of concentrated 
M. hyopneumoniae harvested from the flask culture. Three batches of the 
vaccine were prepared from flask cul tu res which had. growth i ni ti ati ng 
titers of lo-7, 10-9 , and lo-9 . On the day of immunization, the vaccine was 
heat-inactivated at s2°c for 30 minutes and incomplete Freund's adjuvant 
· was added. 
Twe 1 ve pneumonia-free pi gs 12 to 14 weeks old were used. The pi gs 
were randomly grouped into 7 vaccinates and 5 nonvaccinated controls. 
The animals were housed in three isolation rooms: unit #8 housed 4 
vaccinates; unit #7 contained 3 vaccinates and 1 nonvaccinate, and unit #3 
housed the other 4 nonvacci nates. A 11 the p_i gs were fed a pig grower 
ration which was mixed and supplied by the Iowa State University Swine 
Nutrition Farm. This feed is known to contain no antibiotics. It was 
necessary to use this special feed because· the r_egular stock of commercial 
swine feed at the Veterinary Medical Research .Institute was suspected of 
containi_ng some type of .ti· hyopneumoniae inh1biti_ng substance (see 
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appropriate section below). Although all the pigs had been on the . . 
commercial VM.RI. feed before they were selected for the experiment, they· 
were fed only the Swine Nutrition feed for the entire duration of the 
trial. The vaccinates were inmunized three times at one-week intervals; 
lml of the vaccine was administered subcutaneously in the flank to each 
pig. In addition to the subcutaneous i njecti ens, footpad i no cul ati ens 
(0 .. 2ml per pig) were given to the 3 vaccinates in isolation unit #7. The 
footpad booster injections were administered at the same time as the second 
and third subcutaneous injections. 
Two weeks after the third inmunization, the vaccinates and non-
vaccinated controls were challenged by intranasal instillation of low 
passage (passages 39 and 40) of !1· hyopneumoniae fluid culture. Challenge 
inoculations were administered on three consecutive days. Bl.cod was 
collected weekly for serologic tests. Five weeks after challenge, all 
pigs were necropsied. 
Studies on the Virulence of the .Challenge Organism 
(!1. hyopneumoniae) and the Effect of .Age of the 
Pigs on Susceptibility to Experimental Infection 
The unsuccessful attempts to infect any of the 12 nonvaccinated 
control pigs in Immunization Experiment III and the failure to infect 3 
pre-trial pigs by intranasal inoculations with broth cultures of 
!1· hyopneumonia (low and high passages) prompted the speculation that the 
virulence or pathogenicity of the test organism might have been lost or. 
significantly reduced under the laboratory conditions. The fact that the 
pigs were 6 to 8 months old at the time of challenge inoculations and 
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that none of the P.igs responded to challenge exposure with lllYCoplasmal 
pneumonic lung! suspension raised the possibility that .age resistance might 
be responsible for the failure of the pigs to develop pneumonia. The 
followi.ng experiment was then des.igned to determine the validity of either 
or both of these possibilities. 
A total of 12 my cop las ma l pneumonia-free P.i gs, cons isti.ng of 6 young 
pigs (4 weeks old) and 6 old pigs (8 months and .older) were used in the 
trial. The you.ng pigs were housed in two isolation units, each unit 
containi.ng 3 you.ng pigs. The old P.igs were similarly housed in two 
separate isolation units, with 3 P.igs. in each unit. The pigs were fed the 
regular VMRI pig. grower throughout the course of the experiment. Three 
you.ng pigs and 3 old P.igs were inoculated intranasally with low Passage 
broth culture of !1· hyopneumoniae; 3 young pigs and 3 old pigs were 
inoculated with high Passage broth culture. 
The fol lowi.ng is a brief history of the low pass.age culture used· as 
inoculum: 
A lyophil i zed vi al of 18th pass.age of !1· hyopneumoni ae which 
had been stored at -20°c since December, 1965 was reconstituted 
in May, 1971 and three more serial pass.ages were made at 3-day 
intervals. Thirty-six-hour broth cultures of passage 21 were 
stored frozen at -20°c. After the first 24 hours in the 
freezer, one tube of the 21st pass.age had a. growth i ni ti ati ng 
. 't f lo- 7... M h t1 er o In arc , 1972 one tube of the frozen pass.age 
21 was thawed and serial passages were made at 3 to 4-day 
intervals. The 24th, 25th, and 26th pass.ages were used in the 
intranasal inoculation of the experimental P.igs; these cultures 
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-4 -5 -6 had. growth initiating titers .of 10 , 10 , and 10 , 
respectively. 
The h,igh Passage inoculum consisted of the 27lst and 272nd 
passages of broth cultures bf Ji. hyopneumoniae which were 
maintained in the laboratory and continually transferred at 
,.-2 to 3-day intervals. The cultures had growth initiating 
titers of l·o-8 or greater. 
The pigs were exposed intranasally with th.e respective cultures on 
three consecutive days. Blood was collected weekly from all the pigs. 
They were observed for 6 weeks and were then necrops i ed. 
Effect of Swine Feed on Resistance to Infection 
The continued lack of success in efforts to infect pigs with broth 
cultures of Ji. hyopneumoniae or with pneumonic lung suspension suggested 
the possibility that the new supply of feed ·at the Veterinary Medical 
Research Institute (VMRI) contained some kind of inhibiti.ng substance. Two 
experiments were des.igned to test the validity of this possibility. 
Experiment .!_ 
Preparation of feed filtrate Approximately one-half of one pound 
(225gm) of the pelleted VMRI swine feed was blended in the presence of an 
equal amount of distilled water. The resulting materi a 1 was centri'fuged . . 
at 1, 700 rpm (600 x G) for 20 minutes. The supernatant was passed through 
Whatman #1 filter paper and sterilized through 0.45 Millipore filters. The 
filtrate was designated VMRI Feed Filtrate. A small amount of the filtrate 
was inoculated onto hor.se blood agar plates and the plates were incubated 
for 24 hours at 37°C as a sterility check. 
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Sens i ti vi ty tests Two types of sensitivity tests were performed 
on E.agle's base medium .agar plates. About 0.5ml of a 2-day broth culture 
of M. hyopneum6ni'ae (high pass.age) was inoculated onto the plates. The 
plates were carefully rotated to allow the culture to uniformly cover the 
surface. Sterile, blank filter paper discs 1 were soaked in the VMRI feed 
filtrate. After ridding the discs of excess moisture, they were placed 
on the inoculated plates. Two to 3 discs were placed on each plate. 
Sterile, blank ·discs that were not dipped in feed filtrate were. placed on 
a number of inoculated plates as controls. 
For the other type of sensitivity test, 2ml of broth culture of 
M. hyopneumoniae {h.igh pass.age) was mixed with equal volume of the feed 
filtrate. About O.Sml of the mixture was inoculated onto Eagle's base 
medium agar plates. Plates inoculated with the· culture alone were also 
used as controls .. 
Both types of sensitivity tests were repeated, usi.ng the low passage 
culture of !1_.· hyopneumoniae. All inoculated plates were incubated in a 
co2 incubator at 37°c. Plates were examined daily for 4 to 5 days with the 
aid of a light microscope. 
Comparison of VMRI feed and feed from Swine Nutrition Farm2 A 
filtrate of the Swine Nutrition feed was prepared in the same manner as the 
VMRI feed filtrate. The Swine Nutrition feed was known to contain no 
antibiotics. The inhibition activity of the! different feed filtrates was 
1 Di fco Laboratories, Detroit, Mi ch_i gan. 
2This feed was mixed and supplied by the Iowa State .University Swine 
Nutrition Farm ·by special arrangement. 
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compared by the disc sensitivity test, as described above .. 
Both filtrates were also compared by a tube-dilution technique. 
Two-fold serial dilution of each .filtrate was made in. glass tubes containing 
Eagle's base medium. The dilutions of each fi.ltrate were made in dupli-
cates. One row of the tube-dilutions of each filtrate was inoculated 
with 0.5ml of M. hyopneumoniae culture. The second 'row of serial dilutions 
of each filtrate served as uninoculated controls. All tubes were incubated 
at 37°c. Inoculated tubes were che~ked daily for 7 days for growth of 
!1_. hyopneumoniae, each inoculated dilution being compared with its 
equivalent uninoculated control. 
Sensitivity tests of individual components of the swine feed 
Attempts were made to determine if any one of the various components of 
the feed accounted for the i nhi bi ti on activity. The individual ingredients 
used in compounding the VMRI commercial feed were not available. However, 
the Swine Nutrition feed contained similar components as the VMRI feed. 
Therefore, filtrates of each of the followi.ng components of the Swine 
Nutrition feed were prepared: ground corn, soybean meal, vitamin premix, 
dicalcium phosphate, calcium carbonate, iodized salt, and trace mineral 
premix. The disc sensitivity tests wer.e performed with the filtrate 
prepared from each feed component. 
Experiment !l 
This trial was carried out to verify the effect of source of feed on 
the response of P.igs to infection with !1_. hyopneumoniae. 
Eight pneumonia-free pigs, 4 weeks old, were housed in two isolation 
units, each unit containi.ng 4 randomly selected animals. P.igs in one unit 
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were fed the VMRI feed ttiro.ughout the course of the experiment. The pi gs 
in the other unit were placed on the Swine Nutrition feed. Each of the 
pigs was inoculated intranasally with mycoplasmal pneumonic lu_ng suspension. 
The pneumoni c 1 ung came from one of the infected nonvacci nated contro 1 s 
(pig #7og2) in Experiment IV. Mycoplasma hyopneumoniae was recovered from 
this lung. No bacteria were detected. The pigs were exposed intranasally 
on three consecutive days. Five weeks after exposure all the p_igs were 
necropsied. 
In addition to the two experiments, samples of the pelleted VMRI feed 
were sent to the Animal Science Department, Iowa State University for 
t "b. t" 1 an 1 i o 1 cs assay. Feed samples were also sent to the American Cyanamid 
Company, and to the Eli Lilly Company for antibiotic assay. 
1Antibiotic assay was done by Dr. M. H. Jurgens, Assoc. Prof. Animal 
Science Department. 
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RESULTS 
Growth of .!1· hyopneumoniae 
Liquid medium 
The growth of .!1· hyopneumoniae in the .complete Eagle's base medium 
was evidenced after 2 or 3-day incubation by an acid pH change and by an 
increased turbidity to the medium. Slight sediment was produced which 
formed a delicate spiral when the incubated tube was gently swirled. 
Solid medium 
Colonies fanned by M. hyopneumoniae on E.agle's base medium .agar 
plates were not visible macroscopically but were visible at lOOX magnifica-
. ti on of the compound light microscope. The colonies had a tendency to 
grow into the agar, making it necessary to focus slightly lower than normal 
to see them. .!1· hyopneumoni ae co 1 oni es 1 acked the "fried egg" or "film 
and spot" appearance characteristic of other swine my cop 1 as ma. Typi ca 1 
colonies were translucent, coarsely granular, and 0.01 to 0.05mm (10 to 
50µ) in size. Early colonies (2 to 3 days growth) were round and slightly 
raised with uniform borders; occasionally young colonies with irregular 
borders were observed. By the 4th to 8th day of incubation, the colonies 
became larger, less· translucent, more granular, and irregular in shape. 
Immunization Trials 
Experiment l: Vaccination of~ already infected with .!1· hyopneumoniae 
The results of the serologic response of pigs naturally infected and 
then immunized and of the infected nonimmunized controls are summarized in 
Tab 1 e 1 . One of the vaccinates died about 20 minutes after receiving the 
Table 1. Comp lement-fi xi ng antibodies a against !:!• hj:'.OE!neumoni ae in pi gs infected and then vaccinated 
Weeks after first vaccination 
Pre- Pneumonia 
Pig nos. vaccination 1 2 3 4 5 6 7 8 9 score (%) 
6100 8 32 128 256 512 2048 512 512 512 512 3 
6102 16 16 128 256 512 1024 1024 1024 512 512 ob 
6150 32 32 128 128 256 512 512 512 256 256 0 
6162 64 128 128 128 256 256 128 128 64 64 ob 
-~ 
Average 30 52 128 192 384 960 544 544 336 336 
Controls (infected but not vaccinated) 
61018 8 8 16 16 32 64 64 32 16 32 0 
"' 61016 8 8 16 32 64 32 32 16 32 32 3 00 
6130 32 128 128 512 512 512 256 256 256 128 6b 
6161 32 64 64 128. 64 64 32 32 32 32 0 
6154 128 64 64 64 32 64 32 64 64 64 3b 
Average 52 54 58 150 141 147 84 80 80 58 
aCF titers are expressed as the reciprocal of the highest serum dilution in which 70% or more of 
the RBC remained intact. 
bscars in the lung. 
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second inoculation; the animal probably died of shock as no gross pathology 
was observed at necropsy. Both the infected vaccinates and infected 
nonvaccinated controls remained serologically positive throughout the 
duration of the trial. 'However, the vaccinates maintained higher levels 
of CF antibody than did the nonvaccinates. Although the vaccinates had 
slightly lower pre-vaccination average titers than the controls, the post-
vaccination average titers of the vaccinates were higher than those of the 
controls (Figure l). The vaccinates attained maximal antibody level, 
ranging from 256 to 2048, during the fifth week after primary immunization. 
One of the 4 infected vaccinates (pig #6100) had gross pneumonic 
lesions (3%), whereas 3 of the 5 infected nonvaccinates had gross lung 
lesions, ranging in extent from 3 to 6% of the total lung. Two of the 3 
vaccinates without. gross lesions, and 2 of the controls .with lesions had 
scars in the lungs Which probably indicated healing. Although pig #6100 
had a CF antibody titer as high as 2048 in the 5th week, it was the only 
vaccinate that. had gross lesions at necropsy. Similarly, pig #6130, which 
maintained the highest titer among the controls, had the highest pneumonic 
score (6%). 
Expe ri men t .!l 
A summary of the CF antibody titers of pigs vaccinated with either the ' · 
fl ask-anti gen or the lung-anti gen and the response of the pi gs to cha 11 enge 
inoculation is presented in Table 2. All 4 negative controls 
(nonvaccinated and noninfected) remained serologically negative and were 
pneumonia-free at necropsy. Three of the 4 positive controls 
(nonvaccinated but infected) became serologically positive following' the 
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Table 2. CF antibody titersa and response to 
with flask-antigen or lung-antigen 
challenge exposure in pi gs vaccinated subcutaenously 
Weeks after first vaccination 
Pig . Pre- l 2 3 4 5 7 11 Pneumonia Microscopic 
Treatment nos. vaccination (challenge) (necropsy) score (%) lesions 
Fl ask- 6450B <8 <8 64 256 512 2048 512 64 0 Negative 
anti gen 6421B <8 <8 128 512 512 1024 512 64 3 Positive 
6420B <8 <8 64 256 . 256 512 512 32 0 Negative 
6422G <8 <8 128 256 256 256 128 16 0 Negative 
Total = 1/4 
Lu.ng- 6451B <8 <8 <8 <8 <8 <8 <8 <8 0 Positive 
anti gen 6450G <8 <8 <8 <8 <8 <8 <8 <8 0 Positive 
6452B <8 <8 <8 <8 <8 <8 <8 <8 0 Negative ..... ~ 
6454B <8 <8 <8 <8 <8 <8 <8 <8 4 Positive 
Total = 3/4 
Positive 6460B <8 <8 <8 <8 <8 <8 <8 <8 0 Negative 
control 6455B <8 <8 <8 <8 <8 <8 <8 32 3 Positive 
6453G <8 <8 <8 <8 <8 <8 <8 64 3 Positive 
6461B <8 <8 <8 <8 <8 <8 <8 16 2 Pos.i ti ve 
Total = 3/4 
Negati veb 
control 
aCF titers are expressed as the reciprocal of the highest serum dil~tion in which 70% or more of 
RBC remained intact. 
bAll the 4 negative control pigs remained serologically negative and all were pneumonia-free at 
necropsy. 
- ---------------
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challenge inoculations and all 3 had gross pneumonic lesions at necropsy. 
The lesions were frequently confined to the apical, cardiac (Figure 2) and 
the intermediate lobes, and appeared as purple to grey colored areas 
clearly demarcated from the normal lung tissues. Microscopically, the 
lesions were characterized by peribronchiolar and perivascular lymphoid 
hyperplasia, alveolar interstitial thickening, and alveolar and bronchiolar 
exudation of septal cells, lymphocytes and neutrophils (Figures 4, 5, 6). 
No complement-fixing antibodies against !1· hyopneumoniae were' detected 
in the serums of pigs vaccinated with the lung-antigen, and all 4 pigs 
remained serologically negative after the intranasal challenge inoculation. 
One of these 4 lung-antigen vaccinates had gross pneumonic lesions ·and two 
vaccinates without gross les i ens had microscopic 1 es i ens of mycojJl as ma 1 
pneumonia (Figure 7). 
Antibodies were not detected in the flask-antigen vaccinates until 
two weeks after the primary vaccination. The CF antibodies of these 
vaccinates at the time of challenge inoculation ranged from 128 to 512. 
One of the 4 flask-antigen vaccinates had gross lesions of pneumonia. 
Experiment I II 
The comp 1 ement-fi xi ng anti body titers produced in pi gs immunized by 
the subcutane.ous, footpad, i ntraperi tone a 1, and i ntratrachea 1 routes are 
shown in Table 3. Three weeks after pri~ary immunization, the antibody 
titers of vaccinates in isolation units #3 and #21 which received both the 
subcutaneous and footpad inoculations, ranged from 128 to 2048. These 
vaccinates maintained high CF titers at the time of the challenge inocula~ 
tions (6th and 11th week). On the other hand, the vaccinates in unit #20 
Figure 2. 
J 
Gross pneumonic lesion from.a pig infected intranasally with 
broth cul tu re of Mycopl asma hycipneumoni ae: Arrow points at 
clearly demarcated grey CO·lored area in the cardiac lobe of 
the l u.n9 · 

Figure 3. Lung from uninoculated control pig. Note absence of lesions. 
Hematoxylin and eosin stain. XlOO 
F.i gure 4. Peribronchiolar and perivascular lymphoid hyperplasia, alveolar 
interstitial thickening, and septal cell proliferation. Lesions 
.from control (nonvacdnated) pig i no cul ated i ntranas.al ly with 
M. hyopneumoniae broth culture. Hematoxylin and eosin stain. · 
x100, 

,J. 
Figure 5. 
Figure 6. 
Peribronchiolar ly!llphoid hyperplasia ·and bro_nchiolar exudation 
of lymphoid .cells and neutrophils: Lesion from nonvaccinated 
control P.ig inoculated with broth .culture of M. ·hyopneumoniae.-
Hematoxylin and eosin stain. X430 
Perivascular lymphoid hyperplasia. Note migration of lymphoid 
cells from the lumen of the blood vessel. Lesion from a control 
pig.inoculated with broth culture of·!.1· hyopneumoniae. 
Hematoxylin and eosin stain. X430 

Figure 7. 
Figure 8. 
Lymphoid hyperplasia and alveolar infiltration of lymphoid 
cells and n!;!utrophils. Lesion from a pig vaccinated with 
lung-antigen. Pig had no gross lesion. Hematoxylin and 
eos in s ta i n . X430 · · 
Lung from a pig challenged intranasally with M. hyopneumoniae 
fluid culture· and pneu.monic lung suspension. (Experiment #3). 
Atele.ctas is. Note absence of peribronchiol ar. lymphoid reaction. 
Hematoxy~.in and eosin stain. XlOO 
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Table 3. CF antibodiesa against M. hyopneumoniae in pigs vaccinated by 
the subcutaneous (s/c) ,-footpad, intraperitoneal (i/p), and 
intratracheal (i/tr) routes 
Weeks of trial 
0 1 3 6 8 ll 14 
Pig s/c s/c 2nd 
nos. ·footpad footpad challenge challenge necropsy 
Vaccinates: Unit #3 
Y6680B <8 1024 1024 2048 1024 512 >128 
H6727B <8 128 256 1024 512 128 128 
Y6770B <8 32 64 128 128 64 64 
Y6760B <8 256 256 512 256 256 
Vaccinates: Unit #21 
H6723B <8 512 1024 1024 1024 1024 >128 
Y6772B <8 1024 2048 2048 1024 256 >128 
Y6774B <8 128 1024 1024 1024 512 >128 
v·6764G <8 128 512 512 256 128 
Vaccinates: Unit #20b 
Y6761B <8 <8 <8 <8 ±8 <8 <8 
Y6675B <8 8 32 16 32 32 32 
Y6681B <8 <8 32 32 32 <8 <8 
H6726G <8 64 64 32 32 16 16 
Nonvaccinatesc 
a CF titers are expressed as the reci pro ca 1 of the highest serum 
dilution in which 70% or more of RBC were intact. · 
bvaccinates did not receive the footpad inoculation on first day. 
cAll 12 nonvacciilates remained serologically negative after challenge 
inoculations. 
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which were not given the footpad injection during the primary immunization, 
had a titer range of 8 to 64 both at the 2nd and 3rd weeks; the footpad and 
subcutaneous booster inoculations in the 3rd week did not cause any 
increase in the titers. One of these vaccinates in unit #20 remained 
serologically n.egative after all the immunizations. No CF antibodies 
titers were detected in the serums of the 12 nonvaccinated control pigs 
after they were challenged several times with !1_. hyopneumoniae. 
None of the 12 nonvaccinated controls and the 12 vaccinates.had any 
macroscopic pneumonic lesions at necropsy. Except for occasional mild 
atelectasis (Figure 8), the lungs of all the pigs were microscopically 
normal. 
Experiment IV 
The serologic titers of the vaccinates and their response to challenge 
inoculations are presented in Table 4. Complement-fixing antibodies were 
not detecte'd in pigs immunized with the heat-inactivated vaccine until 2 
weeks after the primary immunization. The 3 vaccinates in isolation unit 
#7 which received footpad immunization in addition to the subcutaneous 
injections had much higher antibody titers than any of the 4 vaccinates 
that received only the subcutaneous inoculations. In the third week post-
vaccination the titers of the 3 vaccinates in unit #7 were 512, 1024, and 
2048, while the other vaccinates had titers of 128 or 256. These three 
vaccinates maintained the higher CF antibody titers throughout the duration 
of the tri a 1. Only one of the 5 nonvacci nated control pi gs developed a 
positive CF titer after the challenge inoculation. 
Two of the 5 control pigs had gross lesions typical of rnycoplasmal 
Table 4. Serologic titersa and response to challenge inoculation 
inactivated M. h~oEneumoniae vaccine (Experiment IV) 
in pi gs irrmunized with heat-
Weeks after first vaccination Gross pneumonia 
Isolation Pig Pre-
4b 
(Estimated) Microscopic 
unit nos. vaccination 1 2 3 5 6 7 ( %) lesion 
#le Y7114G <8 <8 128 512 512 128 64 64 0 Negative 
Y71 ll B <8 <8 128 1024 512 128 64 64 0 Negative 
Y7131 B <8 <B 512 2048 1024 512 <128 <128 0 Negative 
#8 Y7112G <8 <8 128 128 64 64 16 16 0 Negative 
Y7l 30B <8 <8 32 256 256 64 16 16 0 Negative 
Y7132G <8 <8 128 256 256 256 64 64 0 Negative 
Y7131 G <8 <8 128 256 256 64 32 32 0 Negative 
CXl 
NDd NDd 
w 
#3 Y7133G <8 <8 <8 <8 <8 <8 4 Positive 
(Nonvaccinates) Y7115G <8 <8 ND ND <8 <8 <8 <8 0 Mild 
lymphoid 
hyper-
pl asi a 
H7160G <8 <8 ND ND <8 <8 <8 <8 0 0 
H7160B <8 <8 ND ND <8 <8 <8 <8 0 0 
H7092 <8 .<8 ND ND <8 <8 16 32 8 Positive 
aCF titers are expressed as the reciprocal of.the highest serum dilution in which 70% or more of 
RBC remained intact. 
bPigs were challenged intranasally in the 4th week after primary vaccination. 
cVaccinates in unit. #7 were given footpad inoculation on the 2nd and 3rd week in addition to the 
-subcutaneous injections. 
dNot done. 
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pneumonia (4% and 8%, respectively} at necropsy, whereas none of the 7 
vaccinates showed any gross lesions. The characteristic histologic lesions 
in one of the infected pigs (pig #7092) are illustrated in Figures 9 and 10. 
One of the control P.igs without. gross lesions had mild peribronchiolar 
lymphoid infiltration. 
Statistical Analysis of Immunization Results 
Chi-square was used for analysis of the results obtained in the 
immunization trials: The results of this analysis are presented in 
Table 5. 
Table 5. Chi -square analysis of the results of inmunization trials 
Vaccinated Control 
Type of pigs pigs 
Experiment vaccine infected infected x2 
I Live vaccine 1/4 3/5 1.102 NS* 
II 
IV 
Heat-inactivated [ "' flask-ant.igen 
Live lung-antigen 3/4 
Heat-inactivated 
0/7 vaccine 
Combined results of 
heat-inactivated 1/11 
vaccine 
*NS = not significant at p.s..05 level. 
**Significant at p.s..05 level. 
3/4 ] 6.95 NS 
0/4 
2/5 5.51** 
5/9 5.10** 
Figure 9. Lymphoid hyperplasia and a,lveolar infiltration of lymphoid . 
cells and neutrophils.' Tissue from nonvaccinated control pig 
inoculated with· M. hyopneumoniae culture. Hematoxylin and 
eosin stain. X430 · 
Figure 10. Peribronchiolar lymphoid hyperplasia and bronchiolar exudation 
of lymphoid ce 11 s and neutrophil s. Ji ss ue from nonvacci nated 
control pig inoculated with . .!1. h~opneumoniae culture. 
Hematoxylir\ and eosin stain. X4 O 

87 
Influence of Passage Level on the Virulence of 
!1_. hyopneumoniae and the Effect of Age of Pigs 
on Susceptibility to Experimental Infection 
No CF antibodies against !1_. hyopneumoniae were detected in the serums 
of the 3 young pigs and the 3 old pigs exposed intranasally with high 
passage culture of !1_. hyopneumoniae. Similarly, none of the 6 pigs 
(3 young and 3 old) inoculated with the low passage culture of the 
fT\YCoplasma responded serologically. 
No gross lesions of mycoplasma pneumonia were observed in the lungs 
of any of the 12 pigs at necropsy. Histologic examination of the lungs 
was not carried out. 
Effect of Swine Feed on Development of Lesions from 
Challenge Inoculation with M. hyopneumoniae 
Experiment .!_ 
Sensitivity tests of VMRI feed filtrate Wide zones of growth 
inhibition of M. hyopneumoniae were consistently observed in plates 
containing the discs dipped in the VMRI feed fil t rate. Under the lOOX 
magnification of the compound light microscope, inhibition zones were 
observed to extend 0.5 to lnm from the discs. Both the high passage and 
the low passage broth cultures of M. hyopneumoniae were significantly 
inhibited by the feed filtrate . No inhibition zones were observed around 
control discs not dipped in the feed filtrate. 
M. hyopneumoniae colonies did not develop on the plates inoculated 
with a mixture of the feed filtrate and the fT\YCOplasma culture except for a 
few scattered colonies with distorted morphology which were observed in 
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two such plates. Growth inhibition occurred with both the high passage 
and low pass.age cul tu res. Abundant typical colonies were observed fo 
control plates inoculated with the mycoplasma culture only. 
Compariso~ of VMRI Contract feed and Swine Nutrition feed The 
results obtained in the comparisons of the two feed filtrates are 
summarized in Table 6. Wide zones of inhibition {up to lmm) were observed 
around discs soaked in the VMRI feed filtrate, whereas very narrow 
inhibition zones (about O.ln111) were seen around some of the discs dipped 
in the Swine Nutrition feed filtrate. No growth inhibition of 
M. hyopneumoniae occurred around control blank discs. 
Typical M. hyopneumoniae colonies were observed in plates inoculated 
with a mixture of Swine Nutrition feed filtrate and the mycoplasma culture. 
No !1· hyopneumoniae colonies were seen in plates inoculated with a mixture 
of the VMRI feed filtrate and the broth culture. 
In the tube-dilution test, no growth of !1· hyopneumoniae occurred in 
the 1 :2 to 1 :128 dilutions of the. VMRI feed filtrate. Beyond the 1 :128 
dilution of the filtrate growth of the mycoplasma occurred. With the 
Swine Nutrition feed filtrate, inhibition of !1· hyopneumoniae growth 
occurred only in the 1:2 and 1:4 dilutions. 
Sens i ti vi ty tests of i ndi vi dual components of swine feed No growth 
inhibition of M. hyopneumoniae was observed in the disc sensitivity tests 
of filtrates prepared from the following Swine Nutrition feed components: 
ground corn, soybean meal, vitamin premix, di calcium phosphate, calcium 
carbonate, and iodized salt. However, narrow zones of inhibition {0.05 to 
O. lmm) were observed around discs dipped in the filtrate prepared from the 
89 
Table 6. Inhibi,tion of growth 6f M. h~opneumoniae by swine feed filtrate: 
comparison of VMRI feed and eed from Swine Nutrition Farm 
a. Disc Sensitivity .Tests: 
VMRI feed filtrate undiluted 
Wide zone of growth i nhi bi-
ti ori {0.2-0.511111)a 
Swine Nutrition feed filtrate 
undiluted 
Very narrow zone of inhibition 
(0.05mm) 
b. Feed filtrate mixed with equal volume of!'.!· hyopneumoniae broth 
cul tu re: 
VMRI feed 
No growth, i.e., no colonies 
fo'rmed 
c. Tube dilution test: 
1 :2 
1 :4 
1 : 8 
1: 16 
1: 32 
1 :64 
1:128 
1 :256 
1:512 
1: 1024 
VMRI feed 
No growth 
Growth 
II 
II 
Swine Nutrition feed 
Growth, i ;e., typical colonies 
formed 
Swine Nutrition feed 
l :2 
l: 4 
l: 8 
1 : 16 
l: 32 
l: 64 
l: 128 
1:256 
l: 512 
l : l 024 
No growth 
II II 
Growth 
aEs ti mation of size of i nhi bi tion zone as seen with the lOOX magni fi-
cati on of compound light microscope. 
trace mineral premix. In the tube-dilution test, inhibition of mycoplasma 
occurred in the 1:2 and 1:4 dilutions of the trace minerals premix 
filtrate. 
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Antibiotic assay 
The result of the anti bi oti,~ assay of the VMRI swine feed indicated 
that the feed sample was negative for tylocine and tetracycline. 1 The 
American Cyanamid Company gave the following report on the antibiotic 
assay of a sample of the VMRI contract feed: "The sample appeared to 
contain a small amount of crystalline chlortetracycline when examined 
microscopically. Upon assay, the sample ~as found to contain less than 
1 :3gm of chlortetracycline activity per ton of feed. 112 Eli Lilly Company 
reported that the feed sample was negative for· tylocine. 3 
Experiment .!..!. 
All 4 pigs fed the Swine Nutrition feed and' 3 of the 4 pigs on the 
VMRI contract feed responded serologically to the intranasal inoculation of 
mycoplasmal pneumonic lung suspension. Complement-fixing antibodies 
against .!1· hyopneumoniae were detected in the 7 pigs two weeks after the 
intranasal exposure. 
At necropsy, all 4 pigs receiving the Swine Nutrition feed had 
extensive gross lesions of my cop 1 as ma 1 pneumonia. One of these pi gs had 
gross pneumonia score of 15%, another had a score of 15% and two had 20% 
of the 1 ung pneumoni c. The 1 es ions were characterized mi croscopi cal ly by 
1Dr. M. Jurgens, Animal Sci. Dept:, ISU, Ames, Ia. Personal 
conmuni cations.· 1972. 
2Part of a personal· letter to Dr. W. P. Switzer from Dr. Robert G. 
Eggert, American Cyanamid Company, New Jersey. 
3Paul Gorham, Eli Lilly Company, Greenfield, Indiana. Personal 
communication. 
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severe peribror:ichiolar and perivascular lymphoid hyperplasia, alveolar 
interstitial t~ickening, septal cell proliferation and neutrophil infiltra-
tion (Figures Jl and 12). Two of the 4 pigs fed the VMRI contract feed 
had gross lung! lesions; the pneumonic scores were 3% and 4%, respectively. 
One of serologically positive pigs showed nq gross lesions, but micro-
scopically theilung had mild lymphoid cell infiltration. 
Figure 11. 
Figure 12. 
Severe peribronchiolar and perivascular lymphoid hyperplasia, 
alveolar interstitial thickeni.ng, septal cell proliferation 
and bronchiolar exudation of lymphoid cells and neutrophi ls. 
Note hyperplastic nodular formation. Lesions from a pig 
inoculate~ with lu.n~ suspension containing M. hYilpneumoniae. 
He~atoxyl1n and eosin stain. XlOO · 
Peribronchiolar lymphoid hyperplasia and bronchiolar exudation 
of~ lymphoid ·ce 11 s and neutrophi 1 s. Lesion from a P.i g 
i no cu late~ w.i th l llng .. suspension containi.ng !!· hyopneumoni ae. 
Hematoxylin ·and eosin stain. X430 · 
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DISCUSSION 
Recent research by independent groups of investigators has established 
that the etiologic agent of chronic pneumonia variously called "Infections 
' . 
Pneumonia of Pi gs", "Swine Enzooti c Pneumonia", and "Virus Pneumonia of 
Pigs" is a mycoplasma. The causative mycoplasma has been characterized 
and named .!1~ hyopneumoniae (Mar~ and Switzer, 1965). The preferred name 
of this disease is mycoplasmal pneumonia of swine. 
MYcoplasmal pneumonia of swine.probably has worldwide distribution, 
as indicated by the reports cited in the literature review. The chronic 
pneumonia has been described as probably the world's most economically 
important single disease of swine (Switzer, 1970) because of its widespread 
geographical distribution and the enonnous economic loss it causes the 
world's swine industry. In England and United States, the annual economic 
loss due to swine mycoplasmal pneumonia has been estimated in hundreds of 
millions of dollars (Betts, 1956; Young, 1956; Goodwin, 1963; Switzer, 
1970). This. great economic loss is caused, not by any significant 
mortality rate~ but by the chronicity of the disease, high herd morbi.dity, 
loss .of vtgor, i stunted growth and decreased feed efficiency produced in 
affected animals. 
On account of the highly infectious nature of mycopla~mal pneumonia of 
swine, much of the,efforts· in its control have been directed at measures 
which break the cycle of infection. However, such measures as isolation 
and controlled rearing of the breeding stock or depopulation of infected . ' . . 
herd and repop11lation with surgically derived specific pathogen-free (SPF) 
pigs have proved· cumbersome, expensive and not totally reliable. Si1'Jilarly, 
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chemotherapy and chemop,rohylaxis are at present ineffective in the .control 
I 
of the disease! While chlortetracycl ine may prevent the development of 
I 
lesions in pigs infected with M. hyopneumoniae., it does not eliminate the 
organism from 1;he lu.ngs nor does it prevent transmission of the organism 
' 
to in-contact P.igs (Huhn, 1969). These problems and the ihcreasi_ng 
economic effects of the disease in the swine industry have created the 
need for investigations of immunization as an- alternative or complementary 
control measure. There are indications that some immunity is induced in 
swine which have recovered from natural or experimental infection of 
ll\YCOpl asmal pneumonia (Lannek and Bornfors, 1957; Goodwin et _tl., 1969a). 
These su_ggest encouraging prospects for vaccinatiOn as a feasible 
immunoprophylactic measure. 
The objective of the present study was- to evaluate the ability of 
M. h.Yopneumoni ae vaccines to promote recovery in infected· pi gs by enhanCi ng 
the elimination of lesions, and to provide protective immunity in 
susceptible swine. Such' an immunization study required· the production of 
adequate quantities of the mycoplasm antigen and the application of a 
serodiagnostic technique that is·:relative.ly simple;· econcimtcal·, ·-reliable, 
and· specific. 
Successful cul ti vati on of· _!1. hyopneumoni ae in cell-free me di um made 
feasible the .production of sufficient amounts of the antigen. Gentle 
I 
shaking of the culture flasks during incubation was found to be a critical 
factor. Stationary incubation of the flasks resulted in low yield of 
packed cells, Shaking the flasks at a speed greater than· 10 to 15 
oscillations per minute caused an increased precipitation of medium 
proteins. It is not certain why shaking the culture flasks resulted in 
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higher antigen yield. It has been suggested that shaking caused an 
increased aeration of the culture and hence an increased growth ·of the 
mycoplasma (Slavik, 1971). 
A modified microtitration. complement fixation test (Slavik and 
Switzer, 1972) was employed in determining the serologic response of swine 
to experimental infection with _11. hyopneumoiliae and to parenteral immuniza-
tion with vaccines. The CF test was modified by heatfog the test serums 
at 56°C for 30 minutes in order to destroy the natural hemolysins to sheep 
RBC which are present in swine serum. The sensitivity of the test was also 
increased by reconstituting the commercial lyophilized guinea-pig comple-
ment with unheated serum from young normal pigs. This modification 
provided "enhancement" of the guinea-pig complement before its titer was 
determined; it also res to red the. complement-binding activity of the heat-
i nacti vated test serums. It is believed that the normal swine serum 
supplied C'3 component to the guinea-pig complement, which has C'3 as the 
limiting factor (Bankowski et ,tl., 1953; Slavik, 1971). 
Heating the mycoplasma antigen at 52°c to 54°c for 30 minutes before 
its titer was determined yielded' an antigen with a high CF activity and a 
low level of anti-complementary activity. Slavik (1971) has suggested that 
heat-treatment "cleaned" the mycoplasma by removing metabolic wastes and 
medium constituents coating the organism and thereby revealed more specific 
antigenic determinants on the cell. membrane. 
The specificity of the modified CF test had been evaluated by testing 
M. hyopneumoni ae, _11. hyorhi ni s, and _11. hyosynovi ae anti gens against the 
heterologous and homologous antiserums. No cross-reactions were.demon-
strated among these agents of swi.ne mycoplasmal infections. However, 
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nonspeci fi.c reactions with other swine pn_eumoni a agents had not been 
adequately evaluated. Evaluation of the accuracy of the modified CF test 
indicated that it is capable of detecting 85% or more .of p_igs with gross 
lesions of mycoplasmal pneumonia (Switzer, 1972). In the present study, 
all the serol.ogic di_agnoses were supplemented with_ gross and microscopic 
examination of the lungs and, in some cases, by the isolation of the 
11\YCOp 1 asma. 
In the first immunization experiment, antibodies against. 
M. hyopneumoniae were detectable in all the p_igs thro_Lighout the course of 
the trial. At.necropsy, however, one of the p_igs naturally infected and 
then immunized and 2 controls (naturally infected but not immunized) had no 
gross lesions 6f mycopl asmal pneumonia and no scars in the 1 ungs. The most 
likely explanation is that these infected pigs had completely recovered 
from the disease but still had detectable circulating antibodies. The 
infected and then immunized p_igs maintained a higher average antibody titer 
than the infected nonvaccinates (Figure 2). Since only 1 of 4 infected 
vaccinates ·had gross lesions, whereas there were 3 of 5 infected non-
vaccinates with lesions, it appeared that vaccination may-have influenced 
recovery. However, statistical analysis of the results· indicated that 
vaccination had no significant effect in curing the infected animals. Thus, 
whil'e parenteral immunization of p_i gs al ready infected with !1· hyopneumoni ae 
caused an elevation of complement-fixing antibodies, it did not signifi-
cantly enhance'the·elimination or resolution of established lesions. There 
was no correlation between the level of CF antibody and the estimate~ 
percent.age of gross pneumonia. Altho_ugh pig #6100.had a CF titer of 2048 
in the 5th week> it was the only infected vaccinate that had_ gross 
~· 
I 
I 
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pneumonic lesions at necropsy. Similarly, pig #6130:which maintained the 
highest CF titer amo.ng the infected nonvaccinates· had the highest estimated 
pneumonic score (6%). Lam (1970) has reported that intramuscular immuniza-
tion of·pigs already infected with· .!1· hyopneumoniae resulted in more 
extensive microscopic lesions; More severe lymphoid· hyperplasia, alveolar 
lymphoid infiltration, and hyperpl as tic nodular formations were observed 
in the lu.ngs of infected vaccinates than were seen in lu.ngs of infected 
control animals. Microscopic examinations of the lungs were· not made in 
this tri a 1 so the hi stopathol.ogi c effects of subcutaneous vaccination of 
the infected pigs was not evaluated. 
In the second immunization trial, two types-. of ·vaccines were evaluated 
for their abi 1 i ty to provide protective inmuni ty against J1. hyopneumoni ae 
infection. The 1 u.ng-anti gen consisted of a 10% concentration of frozen 
11\YCOpl as ma 1 pneumoni c 1 u.ng suspension. The second vaccine was prepared 
from a 10% suspension of mycoplasma harvested from flask cultures; the 
flask-ant.igen was heat-inactivated and contained·incomplete Freund's 
adjuvant.. No CF antibodies against .!1· hyopneumoni ae were detected in the 
serums of P.igs. vaccinated with the lu.ng-ant.igen. The lu.ng had been 
obtained originally from a pig that had. gross and microscopic lesions 
typical of mycoplasmal pneumonia. Vials of·the same batch of the frozen 
pneumoni c 1 u.ng had been used in previous experiments to induce 11\YCOpl as ma 1 
pneumonia. All these suggested that the pneumonic lu.ng contained viable 
11\YCOplasma. The reason for the poor antigenicity of the lung material is, 
therefore, not clear.and.whether some type of antibodies not detectable by 
.the CF test were induced is not known. The lu.ng-antigen failed to protect 
the immunized :p.igs because 3 of the 4 vaccinates had lesions typical of 
' 
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mycoplasmal pneumonia. 
Among the P.i gs· vaci:i nated with the heat-inactivated, adjuvant-
contai ni ng fl ask-ant.i gen, CF antibodies were not detected unti 1 2 weeks 
after the· primary ·inoculation. Since blood samples were collected at 
7-day intervals, it is probable that antibodies could have been detected 
sometime between the first and second weeks post~vaccination. At the 
time of challe.nge inoculation, the CF titers of the flask-antigen 
vaccinates ranged from 128 to 512. Only one of these 4 vaccinates had 
. gross lesions at· necropsy; however, chi-square analysis of the data showed 
that the subcutaneous· immunizations with the flask-antigen did not 
s.i gnifi cantly protect the P.i gs. 
CF antibodies were detected in 3 of 4 positive control challe.nged 
intranasally with ·.!1· hyopneumoniae; all three zero-positive pigs had 
pneumoni c 1 ungs at necropsy. The remaining positive control was serologi-. . 
cally negative and had no pneumonic lesions. Similarly, all 4 negative 
controls remained serologically n.egative and all were pneumonia-free at 
necropsy. 
The third ·immunization- trial was designed· to evaluate the cumulative 
effect of M. hyopneumoni ae vaccines administered by different routes in 
eliciti.ng resistance to challenge infection. Each vaccinate was immunized 
by the subcutaneous, footpad, peritoneal, and the intratracheal routes. 
The subcutaneous and footpad.vaccinations were given to induce circulating 
serum antibodies; the intraperitoneal vaccination. given after.the admin-
istration of mineral oil was designed to "prime" the immune--responsi ve 
peritoneal macroph.ages which are actively functional in cell-mediated 
immunity; and the· intranasal·irniiunization with inactivated·M. 'hyopneumoniae 
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antigen was made with the hope of eliciting some local immunity (humoral 
or cellular). The reasoning was that if the 11\YCOplasmal antigen was 
actually capable of producing significant protection, then the synergistic 
or cumulative action of humoral antibodies and local or cellular inmunity 
elicited by the different routes of vaccination should-effect such a. 
protection. If protection was achieved, then it would be possible by a 
process of selective elimination in subsequent trials, to find which. 
vaccine and route of administration are best capable of inducing resistance 
to mycoplasmal pneumonia. 
Vaccinates which received both the subcutaneous and footpad injections 
on the first day of inmunization maintained much h_igher an~ibody titer 
than did those vaccinates ·that received only the subcutaneous inoculations. 
It was impossible, however" to interpret the results of this trial 
and to evaluate the protective effect of the vaccines because none of the_ 
12 non.vaccinated control pigs could be infected with challenge inoculation 
of kl· hyopneumoniae. It was not evident why the pigs could not be infected 
when challenged with both the broth culture of the organism and the 
pneumonic lung suspension. But, as a result of it, other experiments were 
performed to evaluate the virulence and pathogeni city of the test organism 
and to determine the effect of age of the pigs on susceptibility to 
infection. 
In the fourth i nmuni zati on trial the pi gs were vaccinated with heat-
i nacti vated, adjuvant-containing 10% suspension of. the harvested mycoplasma 
antigen. As was observed in the third experiment, vaccinates which 
received.footpad inoculations in addition to the subcutaneous inoculations 
developed significantly higher levels of CF antibodies than did those 
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vaccinates that receiyed only the subcutaneous vaccination. It is not 
certain why footpad inoculation, given either during the primary immuniza-
tion or as a booster injectio~, caused the production of higher levels of 
circulating antibodies. One explanation is that the footpad contains a 
rich layer of adipose tissue. The antigen is entrapped in the fat.depot 
and is retained for a longer period of time. The pressure created when an 
animal steps on its .footpads provides a "pumpi,ng action" which releases 
only a small amount of the antigen at a time. The prolonged retention of 
the antigen and its constant but gradual release to antibody-forming sites 
may result in a more prolonged production of antibody and a higher level of 
circulating antibody. When adjuvant-containing antigen is administered 
subcutaneously, a granuloma fs forme9 at the inoculation site. It is 
probable that antigen is retained much longer in the footpad than in the 
granuloma, thereby causing antibody formation over a more extended period.· 
of time.: 
Two of the 5 nonvaccinated controls had. gross pneumoni c lesions and 
one other control pig ha·d a mild lymphoid reaction when the lung· was 
examined microscopically. All 7 vaccinates were protected from the 
challenge infection. The protection conferred by the hea~-inactivated 
J1. hyopneumoniae vaccine was statistically significant. All 3 vaccinates. 
which received both subcutaneous and footpad inoculations as well as all 
4 vaccinates given only the subcutaneous injections were protected. It is 
not known, therefore, if footpad inoculation, which results in. higher CF 
antibody level, also conferred greater protection. Further investigation 
of the protective value of vaccines administered by the footpad route 
should be carried out. 
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When the results of immunization Experiments #2 and #4 are pooled, it 
is noted that only l of 11 pigs vaccinated.with the antigen harvested 
from flask cultures had pneumonic lesions at necropsy. On the other hand, 
5 of 9 nonvaccinates developed lesions typical of mycoplasmal pneumonia: 
Statistical analysis of these data confirmed that the heat-inactivated, 
adjuvant-contai ni ng vaccine administered by subcutaneous or footpad route 
conferred signific.ant protection. At the time of challenge inoculations; 
all the vaccinates that were protected had CF titers ranging from 256 to 
1024. Only pig #6421 (Experiment #2) with a CF titer of 512 had. pneumonic 
lungs. These findings suggested there is correlation between vaccine-
induced circulating antibody titers and protective immunity, or that serum 
antibodies are capable of inducing resistance to challenge infeGtion. 
Goodwin et!}_. (1969b) have reported that intramuscular vaccination with 
formalin-inactivated mycoplasma antigen provided little or no protective 
immunity to mycoplasmal pneumonia, and that any· immuni_ty produced did not. 
correlate with CF serum titers. It is probable that the contrasting 
results reflect differences in the mode of inactivation of the mycoplasma 
antigen and the route of immunization. It is likely that heat-treatment is 
more effective than formal i ni zati on in removing nonspecific me di um 
constituents from the antigen surface and in revealing the more specific 
antigenic determin~nts on the cell membrane. Lam and Switzer (197lb) have 
shown that formalinized .!1· hyopneumoniae vaccine inoculated intranasally 
was ineffective in inducing protective immunity. These workers reported 
that when the M. hyopneumoniae antigen was extracted with ether or was 
lysed with 2% sodium lauryl sulfate (SLS) and then injected intramuscularly 
with adjuvant, significant protection was conferred in vaccinated animals. 
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They also found that passive transfer of serums from the hyperinmunized 
pigs conferred protection to the passively inmunized pigs. These findings 
suggested that the protective immunity was mediated by circulating serum 
antibodies. The probability of such an immune mechanism is supported by 
the results obtained in the present study. These preliminary findings 
indicate that, as with contagious bovine p leuropneumoni a and chronic 
respiratory disease of poultry, 11\YCOplasmal pneumonia of swine may be 
controlled by parenteral immunization with vaccines. 
The failure to infect any of the 12 control P.igs (Experiment #3) with 
both 1 ow passage and high passage cultures of .!1· hyopneumoni ae prompted 
the speculation that the virulence of the test o.rgani sm had been s.i gni fi-
cantly reduced or totally lost under laboratory conditions. The fact that 
the experimental P.igs were 6 to 8 months old at the time of challe.nge 
exposure and that none of the pigs could be infected with pneumonic lung 
sus.pension raised another possibility. Namely that the pigs had become too 
old to be infected. It was considered probable that pigs which are 6 
months or older become more res·istant to infection. An experiment was 
carried out to test the virulence of the broth cultures and the effect of 
age on susceptibility to 11\YCOplasma infection. 
None of the you.ng pigs (4 weeks old) and the old P.igs (8 months and 
older) was infected with the low pass.age culture; similarly, the high 
passage failed to infect any of the young and o 1 d pi gs i no cul ated intra-
nasa lly. These findi.ngs s.uggested that the age of the P.igs could not 
account for their failure to develop pneumonia. This view is supported by 
the successful experimental infection of old pigs in a subsequent inmuniza-
tion· trial (Experinient #4). 
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The laboratory-maintained culture of M. hyopneumoniae had maintained 
growth initiating titer of 10-7 or more. It seemed likely that the 
Tl\YCOplasma was still capable of producing disease in the natural host 
system, although it is probable that growth initiati.ng titer is not an 
appropriate measure of virulence or pathogenicity. The broth culture had 
been used in previous experiments to elicit typical 111YCoplasmal pneumonia 
lesions. More s.ignificantly, when the experimental pigs were fed the Swine 
Nutrition feed instead of the VMRI contract feed, the broth culture was 
used successfully to infect the pigs (Experiment #4). These findings 
indicate that some factor other than the virulence of the test o.rganism 
was responsible for the failure to infect the P.igs. Since only 2 of the 5 
control pigs were infected with the broth culture, the possibility remains 
that the pathogenicity of the Tl\YCOplasma had been altered somewhat by 
1 ab oratory propagation. 
Sensitivity tests of the VMRI feed supplied on the most recent contract 
bid revealed that the feed was inhibitory to M. hyopneumoniae. The. growth 
of the Tl\YCOplasma was consistently inhibited by the· feed filtrate both in 
' 
the solid medium and in fluid medium. A comparison of the VMRI swine feed 
and the feed supplied by the Iowa State University Swine Nutrition Farm 
showed that in dilutions up to 1:128 the VMRI feed filtrate inhibited the 
growth of M. hyopneumoniae. On the other hand, inhibition of the o.rganism 
occurred only in the 1:2 and 1:4 dilutions of the Swine Nutrition feed 
fi 1 trate. There was a s i gni fi cant difference in the i nhi bi ti on caused by 
the two feed filtrates. 
Sensitivity tests of the individual components of the· Swine Nutrition 
feed were performed and only the Trace minerals premix· component was 
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inhibitory to!:!· hyopneumoniae. The Trace minerals premix inhibited the 
organism at the same dilution level as the complete Swine Nutrition mix; 
it is prob ab le, therefore, that the Trace mineral component accounted for 
the s 1 i ght i nhi bi ti on produced by the Swine Nutrition feed. Si nee the 
VMRI feed and Swine Nutrition feed contained essentially the same amount of 
trace minerals at almost exact concentrations, the trace· minerals in the 
VMRI feed could not account for the h.igh degree of inhibition produced by 
the VMRI feed. 
ln. vivo comparison of the effects of the two feeds was done. All 4 
pigs which were fed the Swine Nutrition feed developed extensive lesions of 
mycoplasmal pneumonia following intranasal instillation of pneumonic lung 
suspension. The estimated pneumonic scores were 15% to 20%. In contrast, 
only 2 of 4 pigs which were fed the VMRI feed developed lesions and the 
pneumonic scores were 3% and 4%. The results obtained from these experi-
ments indicated that the VMRI feed contained some water-soluble substance 
which had an i nhi bi tory effect on !:!· hyopneumoniae. The nature of the 
inhibiting substance is not known and it is not certain if the material is 
a feed additive or a naturally occurring inhibitor. Antibiotic assays of 
.the feed showed only an i nsi gni fi cant 1 eve l of the anti biotic chl ortetra-
. cycline which is known to inhibit the growth of M. hyopneumoniae. It is 
possible, though unlikely, that the inhibitor is some other type of feed 
additive antibiotic. The contract for the VMRI ration specifies that under 
no conditions is such to be included in the feed. It has been suggested1 
that the inhibitor is a naturally produced by-product of contaminant mold. 
1switzer;W. "P. Veterinary Medical Research Institute, Personal 
communication. 
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The source of such a mold could be commercially supplied corn or soybean 
meal which had become :moldy before it was incorporated into the· swine 
feed. 
It seems premature to speculate on the significance or nons.ignificance 
of the inhibiti.ng substance. Further investigations are suggested to 
verify the inhibition activity and to determine the· nature of the 
inhibitor. It is quite possible that inhibition reported here is of no 
real significance, and that analysis of future feed supplies may not 
reveal any more activity. If TI\YCOplasmal inhibition is consistently 
·observed, as the results. obtained in the present study indicate, it will 
be important to attempt an identification and characterization of the 
inhibitor. The inhibitor may have potential in the control of swine 
TI\YCoplasmal pneumonia either· as a feed additive or a medication. In any 
case, the results experienced in the current study point out the· desir-
ability of pretesting any feed supply used in future P.ig transmission 
trials before the trial is undertaken. 
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SUMMARY 
Heat-inactivated Mycoplasma hyopneumoniae vaccine mixed with 
incomplete Freund's adjuvant was evaluated for its ability to prevent 
mycoplasmal pneumonia of swine. The protective effect of.a.live vaccine 
prepared from mycoplasma pneumonic lung suspension was also evaluated. 
Efficacy of the vaccines was tested by intranasal challenge inoculation of 
immunized pi gs with either .fi. hyopneumoni ae broth culture or pneumoni c 
lung suspension. The serologic response of the pigs to immunization and 
the challenge infection was determined by a modified microtitration · 
complement-fixation (CF) test. 
The heat-inactivated vaccine injected by the subcutaneous and footpad 
routes protected 10 of 11 pigs from pneumonia. All vaccinated animals 
developed high CF antibody titers. Five of 9 nonvaccinated control pigs 
were infected by the challenge exposure. The pneumonic-lung vaccine failed 
to elicit serologic response or to induce· resistance to mycoplasmal 
pneumonia. 
The ability of a live vaccine to produce recovery of pigs already 
infected with mycoplasmal pneumonia was evaluated. This vaccine did not· 
significantly promote recovery, despite the elevation of CF antibodies 
beyond the level elicited by natural infection. 
The results suggested that, while CF circulating antibodies induced 
by vacci.nati on were associated with protective immunity, they were unable 
to enhance the elimination of established lesions. 
An attempt was made to evaluate the cumulative effect of 
M. hyopneumoni ae vaccines administered by the subcutaneous, footpad, 
107 
intraperitoneal, and intratracheal routes to produce resistance to 
infection. The results of the trial could not be interpreted because of 
the failure to infect any of· the control pigs by intranasal challenge 
i no cul ati ons of broth cul tu res and P.neumoni c l u.ng suspension. The 
. virulence of the mycoplasma was then tested and the effect of age of the 
experimental pigs on susceptibility was also studied. 
Filtrates prepared from the supply of Veterinary Medical Research 
Institute (VMRI) swine feed used in this trial were tested in vitro and 
were found to cause consistent inhibition of growth of!'.!_. hyopneumoniae. 
The feed was compared with feed supplied by the Iowa State University Swine. 
Nutrition Farm. All 4 pigs receiving the Swine Nutrition feed developed 
extensive 111YCOplasmal lesions, following intranasal inoculation of 
pneumonic lung suspension; pneumonia lesions were estimated to be 15% to 
20% of total lung. Only 2 of 4 pi gs receiving the VMRI feed developed 
pneumonic lesions estimated to be 3% and 4% of the total lung. This points 
out the need to pretest feed used in 111Ycoplasmal pneumonia of swine 
transmission trials. 
..... 
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